{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Company Shareholder Approval shall have been obtained.",
        "The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance.",
        "The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC.",
        "The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect and no applicable Law shall be effective that prohibits the consummation of the Merger.",
        "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect."
      ],
      "summary": "The mutual conditions for closing include obtaining shareholder approval, Nasdaq listing approval, SEC Form S-4 effectiveness, absence of legal prohibitions, expiration of HSR Act waiting periods, and obtaining necessary regulatory approvals.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained. (b) The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance. The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC. (c) The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order (whether temporary, preliminary or permanent) of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole) and no applicable Law shall be effective that prohibits the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole). (d) Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated. All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "Each representation and warranty of the Company specified in certain sections must be true and correct in all material respects at the Closing Date.",
        "The Company must have performed and complied in all material respects with all covenants and agreements required under the Agreement at or prior to the Closing Date.",
        "No Company Material Adverse Effect shall have occurred since the date of the Agreement and be continuing.",
        "The Company must deliver to Parent a certificate, dated the Closing Date and signed by an executive officer, certifying that the conditions set forth in Sections 6.3(a), 6.3(b), and 6.3(c) have been satisfied."
      ],
      "summary": "The Parent's obligation to close the transaction is contingent upon the accuracy of the Company's representations, compliance with covenants, absence of a Company Material Adverse Effect, and delivery of a certification by the Company.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "The obligations of Parent and Merger Sub to effect the Merger are further subject to the fulfillment (or waiver by Parent and Merger Sub) at or prior to the Effective Time of the following conditions: (a) Each representation and warranty of the Company... shall be true and correct in all material respect at and as of the Closing Date... (b) The Company shall have performed and complied in all material respects with all covenants and agreements required to be performed or complied with by it under this Agreement at or prior to the Closing Date. (c) No Company Material Adverse Effect shall have occurred since the date of this Agreement and be continuing. (d) The Company shall have delivered to Parent a certificate, dated the Closing Date and signed by an executive officer of the Company, certifying to the effect that the conditions set forth in Sections 6.3(a), 6.3(b) and 6.3(c) have been satisfied.",
      "reference_section": "ARTICLE 6 – Conditions to Consummation of the Merger > Section 6.3 – Conditions to Obligations of Parent and Merger Sub Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "Each representation and warranty of Parent and Merger Sub contained in this Agreement shall be true and correct at and as of the Closing Date.",
        "Parent and Merger Sub shall have performed or complied in all material respects with all covenants and agreements required to be performed or complied with by them under this Agreement at or prior to the Closing Date.",
        "Parent shall have delivered to the Company a certificate, dated the Closing Date and signed by an executive officer of Parent, certifying to the effect that the conditions set forth in Sections 6.2(a) and 6.2(b) have been satisfied."
      ],
      "summary": "The Company must ensure that Parent and Merger Sub's representations and warranties are accurate, they have complied with all covenants, and a certificate confirming these conditions is delivered.",
      "confidence": 0.95,
      "reason": "The conditions to the obligations of the Company are explicitly outlined in Section 6.2.",
      "clause_text": "The obligation of the Company to effect the Merger is further subject to the fulfillment (or waiver by the Company) at or prior to the Effective Time of the following conditions: (a) Each representation and warranty of Parent and Merger sub contained in this Agreement, without giving effect to any qualifications as to materiality or \"Parent Material Adverse Effect\" or other similar qualifications contained therein, shall be true and correct at and as of the Closing Date as if made on the Closing Date, except for representations and warranties that relate to a specific date or time (which need only be true and correct as of such date or time), and except as has not had and would not reasonably be expected to have, individually or in the aggregate with all other failures to be true or correct, a Parent Material Adverse Effect. (b) Parent and Merger Sub shall have performed or complied in all material respects with all covenants and agreements required to be performed or complied with by them under this Agreement at or prior to the Closing Date. (c) Parent shall have delivered to the Company a certificate, dated the Closing Date and signed by an executive officer of Parent, certifying to the effect that the conditions set forth in Sections 6.2(a) and 6.2(b) have been satisfied.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.2 Conditions to Obligations of the Company Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly requires the Company Shareholder Approval as a condition to closing.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "two-thirds (2/3) of the votes cast",
      "summary": "The threshold for Target shareholder approval to close the transaction is the affirmative vote of the shareholders representing not less than two-thirds (2/3) of the votes cast at the Company Meeting.",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "Company Shareholder Approval means the affirmative vote of the shareholders of the Company representing not less than two-thirds (2/3) of the votes cast at the Company Meeting with respect to the approval of this Agreement, the Merger and the consummation of the Transactions.",
      "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Shareholder Approval"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_shareholder_approval_required",
      "answer": false,
      "summary": "",
      "confidence": 1.0,
      "reason": "There is no explicit requirement for the Parent to obtain shareholder approval as a condition to closing.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_shareholder_approval_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "",
      "confidence": 1.0,
      "reason": "The agreement explicitly includes the expiration or termination of the waiting period under the HSR Act as a condition to closing.",
      "clause_text": "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement > (d)"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "The Company Shareholder Approval shall have been obtained.",
        "The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance.",
        "The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC.",
        "The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect.",
        "No applicable Law shall be effective that prohibits the consummation of the Merger.",
        "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect."
      ],
      "summary": "The agreement outlines several customary conditions to closing, including shareholder approval, listing approval, SEC effectiveness, absence of legal prohibitions, expiration of waiting periods, and necessary regulatory approvals.",
      "confidence": 1.0,
      "reason": "The conditions listed are standard in M&A agreements and are explicitly mentioned in the document.",
      "clause_text": "The respective obligations of each party to consummate the Merger shall be subject to the satisfaction (or waiver, if permissible under Law) at or prior to the Effective Time of each of the following conditions: (a) The Company Shareholder Approval shall have been obtained. (b) The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance. The Form S-4 shall have been declared effective by the SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated by the SEC. (c) The consummation of the Merger shall not be restrained, enjoined or prohibited by any Order (whether temporary, preliminary or permanent) of a court of competent jurisdiction or any other Governmental Entity that is continuing and remains in effect (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole) and no applicable Law shall be effective that prohibits the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole). (d) Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated. All waivers, consents, clearances, approvals and authorizations under the Regulatory Laws set forth on Section 6.1(d) of the Company Disclosure Schedule with respect to the Transactions shall have been obtained and shall remain in full force and effect.",
      "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition does not explicitly exclude adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent or its Affiliates.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "Adverse effects resulting from general economic conditions, such as changes in markets, economic downturns, interest rates, inflation, or geopolitical events, are excluded from the definition of Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur: (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes generally affecting companies in the industry or industries in which the Company operates from constituting a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally",
        "summary": "The clause excludes changes generally affecting companies in the industry or industries in which the Company operates from being considered a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes generally affecting companies in the industry or industries in which the Company operates are excluded from the definition of a Company Material Adverse Effect.",
        "clause_text": "changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in the trading price or trading volume of Shares or ADS from constituting a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "Changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "summary": "The clause excludes changes in the trading price or volume of the Company's stock from being considered a Material Adverse Effect, unless the underlying cause of such changes is relevant.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in credit ratings or analyst recommendations from constituting a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company are excluded from the definition of a Company Material Adverse Effect.",
        "summary": "Changes in credit ratings, analyst outlooks, or recommendations are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes in ratings or analyst recommendations are not considered a Company Material Adverse Effect.",
        "clause_text": "any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof,",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof",
        "summary": "The clause excludes changes or proposed changes in applicable Laws, GAAP, or their interpretation or enforcement from being considered a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes natural disasters and weather changes from constituting a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, ... (c) changes due to natural disasters or changes in the weather...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "Changes due to natural disasters or changes in the weather are not considered a Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes changes due to natural disasters or changes in the weather.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes due to natural disasters or changes in the weather shall not constitute a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... changes due to natural disasters or changes in the weather...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes acts of war, terrorism, military conflict, or geopolitical instability from constituting a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement), (d) any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement, (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger), (f) any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board, (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or (h) any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism)",
        "summary": "The clause excludes changes in global or national political conditions, including acts of war, terrorism, and related events, from the definition of a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes pandemics, epidemics, or public health emergencies, including COVID-19, from constituting a Material Adverse Effect.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect...except that Effects...due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions...)",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "Adverse Effects arising out of, resulting from or attributable to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19) shall not constitute or be deemed to contribute to a Company Material Adverse Effect.",
        "summary": "Pandemics, epidemics, or public health emergencies, including COVID-19, are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Adverse Effects arising out of, resulting from or attributable to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement) shall not constitute or be deemed to contribute to a Company Material Adverse Effect.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes effects resulting from the negotiation, announcement, pendency, or consummation of the merger agreement from constituting a Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The negotiation, announcement, pendency or consummation of this Agreement and the Merger are excluded from constituting a Company Material Adverse Effect.",
        "summary": "Effects resulting from the negotiation, announcement, pendency, or consummation of the merger agreement are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly excludes effects from the negotiation, announcement, pendency, or consummation of the agreement from being considered a Company Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect... (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition excludes adverse effects caused by actions or omissions of the Parent or its Affiliates if such actions were expressly approved, consented to, or requested in writing by the Company.",
        "clause_text": "any action taken or refrained from being taken, in each case to which the Company has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Parent Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "Adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent are excluded from the definition of Material Adverse Effect.",
        "summary": "Adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent are excluded from the definition of Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken or refrained from being taken, to which Parent has expressly approved, consented to or requested in writing, shall not constitute a Company Material Adverse Effect.",
        "clause_text": "any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "clause_text": "any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "Failures to meet projections, forecasts, estimates, or internal budgets are excluded from the definition of a Company Material Adverse Effect.",
        "summary": "Failures to meet projections, forecasts, estimates, or internal budgets are excluded from the definition of a Company Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not contain any carve-outs beyond the standard exclusions listed in the prompt.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Actions approved by Parent",
            "excerpt": "any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement"
          },
          {
            "label": "Proceedings related to fiduciary duty or law violations",
            "excerpt": "any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board"
          }
        ],
        "summary": "The MAE clause includes carve-outs for actions approved by Parent and proceedings related to fiduciary duty or law violations.",
        "confidence": 0.9,
        "reason": "The language explicitly excludes these items from constituting a Company Material Adverse Effect.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "standard_mae_carveouts_list",
        "answer": "changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement), any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement, the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger), any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board, changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "summary": "The agreement explicitly lists carve-outs to the definition of Material Adverse Effect, including changes in laws, economic conditions, political conditions, actions approved by Parent, and effects related to the merger announcement.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an \"Effect\") that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement), (d) any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement, (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger), (f) any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board, (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or (h) any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "clause_text": "Company Material Adverse Effect means any change, event, occurrence or development (an 'Effect') that, individually or in the aggregate, has had or would reasonably be expected to have, a material adverse effect on the business, financial condition, assets, liabilities or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries:",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
        "summary": "The MAE definition includes a carve-back for disproportionate impacts on the Company relative to others in its industry for certain carve-outs.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that certain carve-outs do not apply if the effects disproportionately impact the Company relative to its industry.",
        "clause_text": "Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE clause specifies carve-outs are reintroduced under specific conditions, such as when effects disproportionately impact the Company relative to others in the industry.",
        "clause_text": "except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "Effects with respect to clauses (a), (b) and (c) shall be considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries.",
          "For purposes of clause (g), the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred.",
          "For purposes of clause (h), the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred."
        ],
        "summary": "The MAE clause includes carve-back provisions for certain excluded events if they disproportionately impact the Company relative to its industry peers or if the underlying cause of specific changes or failures is considered.",
        "confidence": 0.9,
        "reason": "The clause explicitly states conditions under which excluded events may be reconsidered, such as disproportionate impacts or underlying causes.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries: (a) changes or proposed changes in applicable Laws, GAAP or the interpretation or enforcement thereof, (b) changes in general economic, business, labor or regulatory conditions, or changes in securities, credit or other financial markets, including interests rates or exchange rates, in Taiwan, the United States or globally, or changes generally affecting companies in the industry or industries (including seasonal fluctuations) in which the Company or its Subsidiaries operate in Taiwan, the United States or globally, (c) changes in global or national political conditions (including the outbreak or escalation of war (whether or not declared), military action or operation, sabotage, civil unrest, civil disobedience, national or international calamity, the outbreak of hostilities or acts of terrorism), changes due to natural disasters or changes in the weather or changes due to the outbreak or worsening of an epidemic, pandemic or other health crisis (including COVID-19, or any COVID-19 Measures or Permitted Actions or changes in such COVID-19 Measures or Permitted Actions after the date of this Agreement), (d) any action taken or refrained from being taken, in each case to which Parent has expressly approved, consented to or requested in writing (including by email) that such action be taken or refrained from being taken following the date of this Agreement, (e) the negotiation, announcement, pendency or consummation of this Agreement and the Merger, including the identity of, or the effect of any fact or circumstance relating to, Parent or any of its affiliates (provided that this clause (e) shall not apply to any representation or warranty to the extent the purpose of such representation or warranty is to address the consequences resulting from the negotiation, announcement, pendency, or consummation of this Agreement and the Merger), (f) any Proceeding arising from allegations of breach of fiduciary duty or violation of Law relating to the negotiation of this Agreement or any Competing Proposal or the approval of this Agreement or the Transactions by the Company Board, (g) changes in the trading price or trading volume of Shares or ADS or any suspension of trading, or any changes in the ratings or the ratings outlook for the Company by any applicable rating agency or changes in any analyst's recommendations or ratings with respect to the Company (provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or (h) any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The MAE definition includes language indicating that the underlying causes of changes in stock price or failures to meet projections may be considered in determining a Material Adverse Effect.",
        "clause_text": "provided, that for purposes of this clause (g) the underlying cause of such change may be taken into account in determining whether a Company Material Adverse Effect has occurred) or (h) any failure by the Company or any of its Subsidiaries to meet any revenue, earnings or other financial projections or forecasts (provided, that for purposes of this clause (h) the underlying cause of such failure may be taken into account in determining whether a Company Material Adverse Effect has occurred).",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "Effects with respect to clauses (a), (b), and (c) may be considered if they adversely and disproportionately impact the Company and its Subsidiaries relative to other companies in the same industry.",
        "summary": "The carve-back allows for the consideration of certain adverse Effects if they disproportionately impact the Company compared to its industry peers.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Effects under clauses (a), (b), and (c) can be considered if they disproportionately impact the Company.",
        "clause_text": "provided, however, that adverse Effects arising out of, resulting from or attributable to the following shall not constitute or be deemed to contribute to a Company Material Adverse Effect, and shall not otherwise be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur, except that Effects with respect to clauses (a), (b) and (c) of the below shall be so considered to the extent such Effect adversely and disproportionately impacts the Company and its Subsidiaries, taken as a whole, relative to other companies operating in the same industry or industries",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Company Material Adverse Effect"
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a 'No-Shop' clause as it explicitly restricts the Company from soliciting or initiating discussions with third parties regarding Competing Proposals.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal or engage in any discussions or negotiations with respect thereto...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "The Company is restricted from soliciting, initiating, or encouraging any competing acquisition proposals and from engaging in discussions or negotiations with respect to such proposals, except under specific conditions outlined in the agreement.",
        "summary": "The Company is restricted from soliciting, initiating, or encouraging any competing acquisition proposals and from engaging in discussions or negotiations with respect to such proposals, except under specific conditions outlined in the agreement.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal or engage in any discussions or negotiations with respect thereto...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly requires the Company to notify Parent promptly if it receives any Competing Proposal.",
        "clause_text": "From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, the Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify the Parent of any Competing Proposal or inquiry within forty-eight (48) hours, including the identity of the Third Party and a copy or description of the proposal.",
        "summary": "The Company must notify the Parent of any Competing Proposal or inquiry within forty-eight (48) hours, including the identity of the Third Party and a copy or description of the proposal.",
        "confidence": 0.95,
        "reason": "The clause explicitly requires the Company to notify the Parent of any Competing Proposal or inquiry within a specified timeframe.",
        "clause_text": "From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, the Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal. The Company shall notify Parent promptly (and in any event within forty-eight (48) hours) of the identity of the Third Party making such Competing Proposal or inquiry or request and provide to Parent a copy of such Competing Proposal or inquiry or request (or, where no such copy is available, a reasonable description of the material terms and details thereof).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires the Company to promptly notify Parent of any Competing Proposal or inquiry that could lead to a Competing Proposal, indicating an ongoing update requirement.",
        "clause_text": "From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, the Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "The Company is obligated to promptly notify Parent within forty-eight (48) hours of receiving any Competing Proposal or inquiry that could lead to a Competing Proposal.",
        "summary": "The Company must provide prompt updates to Parent within 48 hours regarding any Competing Proposal or related inquiries.",
        "confidence": 0.9,
        "reason": "The clause specifies a 48-hour notification requirement for Competing Proposals or inquiries.",
        "clause_text": "The Company shall promptly (and in any event within forty-eight (48) hours) notify Parent in the event that the Company receives any Competing Proposal or any inquiry or request for information that could reasonably be expected to lead to a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (d)"
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement allows the target company to engage in discussions or negotiations with a third party that submits a Superior Proposal under certain conditions, such as fiduciary duties and written notice to the buyer.",
        "clause_text": "Notwithstanding anything to the contrary contained in Section 5.5(a), if at any time following the date hereof and prior to the receipt of the Company Shareholder Approval... the Company and its Representatives may, directly or indirectly through the Company's Representatives: (A) furnish information with respect to the Company and its Subsidiaries... and (B) participate or engage in discussions or negotiations with the Third Party making such Competing Proposal...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company and its Representatives may, directly or indirectly through the Company's Representatives: (A) furnish information with respect to the Company and its Subsidiaries (including non-public information) to the Third Party making such Competing Proposal and its Representatives pursuant to (but only pursuant to) one or more Acceptable Confidentiality Agreements and (B) participate or engage in discussions or negotiations with the Third Party making such Competing Proposal and its Representatives regarding such Competing Proposal and any changes thereto, including by making counterproposals thereto; provided, however, that any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party, except to the extent providing Parent or Merger Sub with such information would violate any applicable Law.",
        "summary": "The Company is authorized to engage with third parties if a Superior Proposal is received, allowing information sharing and negotiations under certain conditions.",
        "confidence": 0.95,
        "reason": "The clause explicitly permits the Company to furnish information and engage in negotiations if a Superior Proposal is received, based on fiduciary duty considerations.",
        "clause_text": "The Company and its Representatives may, directly or indirectly through the Company's Representatives: (A) furnish information with respect to the Company and its Subsidiaries (including non-public information) to the Third Party making such Competing Proposal and its Representatives pursuant to (but only pursuant to) one or more Acceptable Confidentiality Agreements and (B) participate or engage in discussions or negotiations with the Third Party making such Competing Proposal and its Representatives regarding such Competing Proposal and any changes thereto, including by making counterproposals thereto; provided, however, that any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party, except to the extent providing Parent or Merger Sub with such information would violate any applicable Law.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer a right to match an initial Superior Proposal received by the target, as indicated by the language allowing the Company to engage in good faith discussions and negotiations with Parent regarding a possible amendment to the Agreement.",
        "clause_text": "during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i) Following receipt by Parent of a Company Notice, if the financial or other material terms of such Competing Proposal are amended prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence, the Company will deliver to Parent a new Company Notice prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence; provided, that the period of negotiation provided in Section 5.5(f)(iv)(the \"Notice Period\") shall instead end at 5:00 p.m. Taiwan time on the third (3rd) Business Day immediately following delivery of such Company Notice, but no such new Company Notice shall shorten the original fourth (4th) Business Day period, and there may be multiple new Notice Periods if there are multiple revisions in price or other material revisions in terms or other material changes.",
        "summary": "The Company must provide Parent with a written notice of a Superior Proposal and engage in good faith negotiations for four business days to allow Parent to amend the agreement.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i) Following receipt by Parent of a Company Notice, if the financial or other material terms of such Competing Proposal are amended prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence, the Company will deliver to Parent a new Company Notice prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence; provided, that the period of negotiation provided in Section 5.5(f)(iv)(the \"Notice Period\") shall instead end at 5:00 p.m. Taiwan time on the third (3rd) Business Day immediately following delivery of such Company Notice, but no such new Company Notice shall shorten the original fourth (4th) Business Day period, and there may be multiple new Notice Periods if there are multiple revisions in price or other material revisions in terms or other material changes.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly provide a renewed right to match for amended proposals.",
        "clause_text": "Following receipt by Parent of a Company Notice, if the financial or other material terms of such Competing Proposal are amended prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence, the Company will deliver to Parent a new Company Notice prior to the Company Board making a Company Change of Recommendation or terminating this Agreement in accordance with the foregoing sentence; provided, that the period of negotiation provided in Section 5.5(f)(iv)(the 'Notice Period') shall instead end at 5:00 p.m. Taiwan time on the third (3rd) Business Day immediately following delivery of such Company Notice, but no such new Company Notice shall shorten the original fourth (4th) Business Day period, and there may be multiple new Notice Periods if there are multiple revisions in price or other material revisions in terms or other material changes.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The board is permitted to make a Company Change of Recommendation in response to a Superior Proposal.",
        "clause_text": "Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may in response to its receipt after the date of this Agreement of a bona fide written Competing Proposal with respect to which the Company is not in material breach of this Section 5.5, make a Company Change of Recommendation or terminate this Agreement to enter into a definitive written agreement providing for such Competing Proposal pursuant to Section 7.1(f) if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that (x) such Competing Proposal constitutes a Superior Proposal...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly allows the Company Board to make a Company Change of Recommendation in response to a Company Intervening Event.",
        "clause_text": "Notwithstanding anything to the contrary contained in this Section 5.5, at any time prior to the receipt of the Company Shareholder Approval, the Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that the failure to make a Company Change of Recommendation would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that the failure to make a Company Change of Recommendation would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands; provided, that the making of such determination shall not in and of itself constitute a Company Change of Recommendation or violation of this Section 5.5, (ii) the Company has provided Parent with a written notice (a \"Company Intervening Event Notice\") of such determination, stating that such notice constitutes a Company Intervening Event Notice, providing a description of the material facts and circumstances giving rise to a Company Intervening Event, and that the Company Board intends to effect a Company Change of Recommendation; provided, that the sole action of giving such Company Intervening Event Notice and the of the Company Board authorizing and disclosing (to the extent legally required) such Company Intervening Event Notice shall not constitute a Company Change of Recommendation or a violation of this Section 5.5); and (iii) during the period commencing on the date of Parent's receipt of the Company Intervening Event Notice and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day thereafter (the \"Matching Period\"), has made its Representatives reasonably available to engage, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any proposals made by Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(e)(i).",
        "summary": "The Company Board may change its recommendation due to a Company Intervening Event if it determines in good faith that not doing so would breach fiduciary duties, provides a written notice to Parent, and engages in good faith negotiations with Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows for a change in recommendation due to a Company Intervening Event, detailing the conditions under which this can occur.",
        "clause_text": "The Company Board may make a Company Change of Recommendation in response to a Company Intervening Event if, and only if, (i) the Company Board has determined in good faith after consultation with the Company's outside counsel and financial advisor that the failure to make a Company Change of Recommendation would be reasonably likely to be inconsistent with the fiduciary duties of the members of the Company Board to the Company's shareholders under the Law of the Cayman Islands; provided, that the making of such determination shall not in and of itself constitute a Company Change of Recommendation or violation of this Section 5.5, (ii) the Company has provided Parent with a written notice (a \"Company Intervening Event Notice\") of such determination, stating that such notice constitutes a Company Intervening Event Notice, providing a description of the material facts and circumstances giving rise to a Company Intervening Event, and that the Company Board intends to effect a Company Change of Recommendation; provided, that the sole action of giving such Company Intervening Event Notice and the of the Company Board authorizing and disclosing (to the extent legally required) such Company Intervening Event Notice shall not constitute a Company Change of Recommendation or a violation of this Section 5.5); and (iii) during the period commencing on the date of Parent's receipt of the Company Intervening Event Notice and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day thereafter (the \"Matching Period\"), has made its Representatives reasonably available to engage, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any proposals made by Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(e)(i).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly prohibits the Company from soliciting or initiating any Competing Proposal, indicating the absence of a go-shop provision.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement grants the buyer the right to receive any diligence materials shared with a third party, as indicated by the requirement to provide Parent with substantive non-public information provided to any third party.",
        "clause_text": "provided, however, that any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party",
        "summary": "The Company is obligated to provide Parent with any substantive non-public information shared with a third party in connection with a Competing Proposal within 48 hours.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the obligation to provide Parent with information shared with third parties.",
        "clause_text": "any substantive non-public information concerning the Company or its Subsidiaries provided or made available to any Third Party shall, to the extent not previously provided or made available to Parent or Merger Sub, be provided or made available to Parent or Merger Sub as promptly as reasonably practicable (and in any event within forty-eight (48) hours) after it is provided or made available to such Third Party",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (c)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement imposes restrictions on public statements regarding the Merger or Agreement, requiring prior written consent from the other party, except as required by law.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated pursuant to Article 7, so long as this Agreement is in effect, Parent and Merger Sub, on the one hand, and the Company, on the other, and any of their respective affiliates, shall not issue any press release or make any public statement with respect to the Merger or this Agreement without the prior written consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), except as may be required by applicable Law...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.8 Public Announcements"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation.",
        "summary": "The Company must provide Parent with a written notice of its determination, engage in good faith discussions and negotiations with Parent during a specified period, and consider any proposals made by Parent before making a Company Change of Recommendation.",
        "confidence": 0.9,
        "reason": "The agreement specifies a process involving notice, negotiation, and consideration of Parent's proposals before a recommendation change.",
        "clause_text": "The Company has provided Parent with a written notice (a \"Company Notice\") of such determination stating that such notice constitutes a Company Notice, stating whether the Company Board intends to effect a Company Change of Recommendation or the Company intends to terminate this Agreement, and describing in reasonable detail the reason for such Company Change of Recommendation or termination; provided, that the sole action of giving such Company Notice and of the Company Board in authorizing and disclosing (to the extent legally required) such Company Notice shall not constitute a Company Change of Recommendation, a violation of this Section 5.5 or a termination of this Agreement, (iii) the Company has provided Parent with all agreements and documents, and a copy of all material written communications, relating to such Competing Proposal, (iv) during the period commencing on delivery of the Company Notice to Parent and ending at 5:00 p.m. Taiwan time on the date that is the fourth (4th) Business Day after such delivery, the Company has made its Representatives reasonably available for the purpose of engaging, and the Company has, engaged, in good faith discussions and negotiations with Parent and its Representatives (to the extent Parent desired to negotiate) regarding a possible amendment to this Agreement and has considered in good faith any written proposals made by Parent that if accepted by the Company would be binding upon Parent, and after taking account of Parent's proposals, if any, the Company Board again makes the determination set forth in Section 5.5(f)(i).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (f)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to obtain regulatory approvals and satisfy conditions to closing as promptly as practicable.",
        "confidence": 0.9,
        "reason": "The agreement specifies 'reasonable best efforts' as the standard for regulatory efforts, which is a recognized standard in M&A transactions.",
        "clause_text": "Each of the parties agrees to use its reasonable best efforts to (i) take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to cause the conditions to Closing to be satisfied as promptly as reasonably practicable...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR, FTC, DOJ, and SAMR filings",
        "summary": "The effort scope includes reasonable best efforts for filings and responses under the HSR Act, FTC, DOJ, and SAMR.",
        "confidence": 0.9,
        "reason": "The clause specifies the requirement to file pre-merger notifications under the HSR Act and respond to inquiries from the FTC, DOJ, and SAMR.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable... Parent and the Company shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity, including the Federal Trade Commission (the \"FTC\"), Antitrust Division of the U.S. Department of Justice (the \"DOJ\") and the People's Republic of China's State Administration for Market Regulation (\"SAMR\")...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "The expiration or termination of the HSR waiting period is a condition to closing the merger.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the expiration or termination of the HSR waiting period is a condition to closing.",
        "clause_text": "Any applicable waiting period, together with any extensions thereof, under the HSR Act shall have expired or been terminated.",
        "reference_section": "ARTICLE Article 6 Conditions to Consummation of the Merger > Section 6.1 Conditions to Obligations of Each Party Under This Agreement > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": "15",
        "summary": "The parties are required to prepare and file the pre-merger notification under the HSR Act no later than fifteen (15) Business Days after execution of the Agreement.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline of fifteen (15) Business Days for the HSR filing.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b) > (i)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 15 Business Days of execution; filing required under HSR Act as a condition to closing.",
        "summary": "The parties must file the pre-merger notification under the HSR Act within 15 Business Days of execution, and this filing is required as a condition to closing.",
        "confidence": 0.95,
        "reason": "The document specifies a clear deadline for HSR filing and its necessity for closing.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b) > (i)"
      }
    ],
    "regulatory_fillings_cfius": [
      {
        "section": "best_efforts",
        "field_name": "cfius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit mention of a CFIUS filing or clearance requirement in the provided sections.",
        "clause_text": "FDI Laws means any federal, state, provincial, territorial and foreign statutes, rules, regulations, governmental orders, administrative and judicial doctrines and other applicable Laws that are designed or intended to prohibit, restrict or regulate investments by Persons that are deemed a foreign entity or that may pose a threat to national security.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > FDI Laws"
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "Foreign filings may be required under applicable non-U.S. laws as the agreement includes obligations to file under applicable Regulatory Laws, which encompass Competition Laws and FDI Laws.",
        "confidence": 0.9,
        "reason": "The agreement refers to 'Regulatory Laws' which include foreign competition and FDI laws, implying foreign filing obligations.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement requires filings under 'other Regulatory Laws,' which implies foreign filings are necessary.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that Parent and its affiliates are not required to undertake structural or conduct remedies such as divestitures or hold-separate arrangements.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent is not required to divest any of its businesses.",
        "summary": "The agreement explicitly states that Parent is not required to divest any of its businesses or assets, even if necessary to avoid legal impediments to the merger.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent is not obligated to divest any assets or businesses.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (f)"
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "summary": "The agreement requires the parties to defend lawsuits or other legal proceedings challenging the merger or its consummation.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the obligation to defend lawsuits or legal proceedings related to the merger.",
        "clause_text": "to defend lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Merger and the other Transactions.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a) > (iv)"
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "summary": "Buyer must litigate regulatory challenges unless conditions to closing are impossible.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "to defend lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Merger and the other Transactions.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (a) > (iv)"
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "buyer_only",
        "summary": "The agreement specifies that the Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals, and waiting-period expirations under Regulatory Laws.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Parent has full control over the strategy and tactics for regulatory clearances.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not contain any clause stating that neither party shall enter into any timing or similar agreement under the HSR Act without the other party’s prior written consent.",
        "clause_text": "The excerpts provided do not mention any restriction on entering into timing agreements under the HSR Act without prior written consent.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings"
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement outlines obligations related to regulatory clearance efforts, including using reasonable best efforts to obtain necessary approvals and clearances.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, each of the parties agrees to use its reasonable best efforts to (i) take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to cause the conditions to Closing to be satisfied as promptly as reasonably practicable...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement restricts the Company from soliciting or engaging in alternative transactions or competing proposals that could interfere with regulatory approvals.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated in accordance with Article 7, and except as otherwise permitted in this Agreement, the Company will not, and it will cause the Subsidiaries of the Company and its and their respective directors and officers, and the Company shall instruct its and its Subsidiaries' financial advisors, investment bankers, legal counsel and other Representatives on behalf of the Company not to: (i) solicit or initiate or knowingly assist, facilitate or encourage any inquiry, proposal or offer that constitutes or would be reasonably expected to lead to a Competing Proposal or engage in any discussions or negotiations with respect thereto...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit language specifying a concrete deadline for certifying compliance with the Second Request under the HSR Act.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as reasonably practicable",
        "summary": "The agreement requires parties to use reasonable best efforts to file necessary documentation and respond to governmental inquiries as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The phrase 'as promptly as reasonably practicable' is used in the context of regulatory filings and governmental cooperation.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "Both parties are responsible for certifying compliance with the Second Request under the HSR Act, as they are required to cooperate and coordinate in making Regulatory Filings and responding to inquiries from Governmental Entities.",
        "confidence": 0.9,
        "reason": "The agreement requires both parties to cooperate and coordinate in making Regulatory Filings and responding to inquiries, implying joint responsibility.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly mention or implicitly refer to FTC warning letters or similar preliminary regulatory communications.",
        "clause_text": "Parent and the Company shall use their respective reasonable best efforts to respond as promptly as reasonably practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity, including the Federal Trade Commission (the 'FTC'), Antitrust Division of the U.S. Department of Justice (the 'DOJ') and the People's Republic of China's State Administration for Market Regulation ('SAMR') in connection with the matters in Section 5.6(a) and this Section 5.6(b).",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Parent shall prepare and file with the SEC a preliminary Form S-4 within forty-five (45) days after the date of this Agreement.",
          "The Company will cause the Form S-4 and the Proxy Statement to be mailed to its shareholders within five (5) Business Days of the date the Form S-4 is declared effective by the SEC.",
          "The Company will hold a meeting of the Company shareholders within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4, unless extended with Parent's prior written consent.",
          "No adjournments of the Company Meeting shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days."
        ],
        "summary": "The agreement specifies deadlines for filing and mailing documents and holding shareholder meetings, including a 45-day deadline for filing Form S-4, a 5-business-day deadline for mailing after SEC effectiveness, and a 45-day deadline for holding the shareholder meeting post-mailing.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4... The Company will cause the Form S-4 and the Proxy Statement to be mailed to its shareholders within five (5) Business Days of the date the Form S-4 is declared effective by the SEC... within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a), (b), (e)"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "Parent has full control over the strategy and tactics for obtaining regulatory clearances, but must consider the Company's proposals.",
            "section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (e)",
            "review_required": true
          },
          {
            "summary": "Parent is not required to take certain actions, such as divestitures or conduct remedies, that would materially affect its business.",
            "section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (f)",
            "review_required": true
          },
          {
            "summary": "Parent is restricted from engaging in M&A Activity that could delay or prevent regulatory approvals, except for certain activities in China.",
            "section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (g)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly mention an obligation to obtain prior approval from a third party for future actions beyond the merger itself.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, each of the parties agrees to use its reasonable best efforts to (i) take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under this Agreement and applicable Law to cause the conditions to Closing to be satisfied as promptly as reasonably practicable...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Parent",
        "summary": "Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Parent shall have full control over regulatory process decisions.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that Parent shall have full control over devising the strategy and tactics for obtaining regulatory clearances, excluding Remedy Actions.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement places express limitations on the Buyer's obligation to take Remedy Actions, such as not requiring Parent to sell, divest, or take actions that would materially affect its business.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding, (B) undertake any behavior or conduct remedy that would be material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole, or (C) to take any action or make any omission that would violate applicable Law.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document contains material carveouts and qualifications that limit the Buyer's obligations, indicating that the Buyer is not under a Hell-or-High-Water obligation.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, it is expressly understood and agreed that none of Parent or any of its affiliates shall be required to propose, negotiate, commit to or effect, execute or carry out agreements, enter into consent decrees or submit to orders providing for, whether by consent decree, national security agreement, letter of assurance, hold separate orders, or otherwise (A) to sell, divest, lease, license, transfer, dispose of, hold separate (through establishment of a trust or otherwise) or otherwise encumber, limit or impair or take any other action with respect to Parent's or any of its affiliates' or the Company's or and of its Subsidiary's ability to own or operate any assets or categories of assets, properties, businesses or product lines of Parent or any of its affiliates or the Company or any of its Subsidiaries, even if required in order to avoid the entry of, or to effect the lifting or dissolution of, any injunction, temporary restraining order, or other Order in any suit or Proceeding, (B) undertake any behavior or conduct remedy that would be material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole, or (C) to take any action or make any omission that would violate applicable Law.",
        "reference_section": "ARTICLE V – Covenants > Section 5.6 – Appropriate Action; Consents; Filings > (f)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Not applicable",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document obligates the parties to use reasonable best efforts to file necessary applications, including under the HSR Act, and to respond to any requests for additional information.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "The agreement does not specify a limit on the number of HSR refilings.",
        "confidence": 0.8,
        "reason": "The provided excerpts do not mention any limit or specification regarding the number of HSR refilings.",
        "clause_text": "Each party hereto agrees to use its reasonable best efforts to file, as soon as practicable and advisable after the date of this Agreement, all applications, notices, petitions and filings required or recommended to be filed by such party with any Governmental Entity with respect to the Merger and the other Transactions, and to submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "union_item": [
      {
        "section": "best_efforts",
        "field_name": "union_efforts_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that neither the Company nor any Subsidiary is a party to or bound by any labor agreement, collective bargaining agreement, or any other labor-related agreements or arrangements with any labor union, labor organization or works council.",
        "clause_text": "Neither the Company nor any Subsidiary of the Company is a party to or bound by any labor agreement, collective bargaining agreement, or any other labor-related agreements or arrangements with any labor union, labor organization or works council.",
        "reference_section": "ARTICLE Article 3 Representations and Warranties of the Company > Section 3.12 Employee and Labor Matters > (b) > (i)"
      },
      {
        "section": "best_efforts",
        "field_name": "union_consultation_timeframe",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "union_agreement_obligation_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_strategy_control_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_strategy_control_rights",
        "answer": "Parent",
        "summary": "The agreement grants Parent full control over devising the strategy and tactics for obtaining regulatory clearances, approvals, and waiting-period expirations.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that Parent shall have full control over regulatory strategy.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      }
    ],
    "regulatory_delay_control_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_delay_control_rights",
        "answer": "Parent",
        "summary": "The agreement grants Parent full control over devising the strategy and tactics for obtaining regulatory clearances, approvals, and waiting-period expirations, including any filings, notifications, submissions, and communications with Governmental Entities.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Parent shall have full control over the regulatory strategy and tactics.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      }
    ],
    "remedy_consent_required_by_target": [
      {
        "section": "best_efforts",
        "field_name": "remedy_consent_required_by_target",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_review_discretion_rights": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_review_discretion_rights",
        "answer": "Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws.",
        "summary": "Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws.",
        "confidence": 0.9,
        "reason": "The document explicitly states that Parent has full control over regulatory strategy and tactics.",
        "clause_text": "Notwithstanding the foregoing or anything else herein to the contrary, the parties agree that Parent shall have full control over devising the strategy and tactics for obtaining clearances, approvals and waiting-period expirations under Regulatory Laws, including any filings, notifications, submissions and communications with or to any Governmental Entity in connection therewith; provided that Parent shall reasonably consider any good faith proposals timely made by the Company or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (e)"
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "February 6, 2023",
        "summary": "The initial 'Outside Date' specified in the agreement is February 6, 2023, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states the Original Outside Date as February 6, 2023.",
        "clause_text": "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date');",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "Automatically to May 5, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to a party whose material breach caused the failure to close by the outside date"
          },
          {
            "Extension Length": "Automatically to August 7, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to a party whose material breach caused the failure to close by the outside date"
          },
          {
            "Extension Length": "10 Business Days after the Outside Date",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Conditions to Closing in Article 6 are satisfied prior to the Outside Date",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to a party whose material breach caused the failure to close by the outside date"
          },
          {
            "Extension Length": "2 Business Days after the last day of any then-pending Matching Period or Marketing Period",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Matching Period or Marketing Period is pending",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to a party whose material breach caused the failure to close by the outside date"
          }
        ],
        "summary": "The Outside Date may be extended automatically under specific conditions, such as satisfying or waiving certain conditions in Article 6, or if a Matching or Marketing Period is pending.",
        "confidence": 0.95,
        "reason": "The agreement specifies automatic extensions under certain conditions, which are standard in M&A agreements.",
        "clause_text": "provided, further, that if on the Original Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to May 5, 2023 (the \"First Extended Outside Date\"); provided, further, that if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the \"Second Extended Outside Date\") (the Original Outside Date as such date may be extended by the First Extended Outside Date and the Second Extended Outside Date, as applicable, the \"Outside Date\"); provided, further, that if the conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on Closing Date), then the definition of the applicable Outside Date shall be deemed to be extended, and shall mean, the date that is ten (10) Business Days after the Outside Date prior to giving effect to this proviso (it being understood that this proviso shall only extend the Outside Date once); provided, further, that the definition of the applicable Outside Date shall be deemed to be extended until the date that is two (2) Business Days after the last day of any then-pending (i) Matching Period or (ii) Marketing Period.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "$132,000,000",
        "summary": "The Company Termination Fee payable by the Target to the Parent is explicitly stated as one hundred thirty two million dollars.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The \"Company Termination Fee\" means one hundred thirty two million dollars ($132,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": "160000000",
        "summary": "The agreement specifies a Parent Termination Fee of $160,000,000 to be paid by the Parent to the Company under certain termination conditions.",
        "confidence": 0.95,
        "reason": "The agreement explicitly defines the Parent Termination Fee as $160,000,000 in the event of termination under specified conditions.",
        "clause_text": "The \"Parent Termination Fee\" means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a provision for a Parent Termination Fee, which is a reverse termination fee, payable by Parent to the Company under certain conditions.",
        "clause_text": "The parties hereto agree that (A) if this Agreement is terminated by Parent or the Company pursuant to (x) Section 7.1(c) ... then Parent shall pay to the Company ... the Parent Termination Fee. The 'Parent Termination Fee' means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "termination_fee_superior_proposal": [
      {
        "section": "termination",
        "field_name": "termination_fee_superior_proposal_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly includes a provision requiring the Company to pay a fee to the Parent upon accepting a Superior Proposal.",
        "clause_text": "The parties hereto agree that if this Agreement is terminated by Parent pursuant to Section 7.1(e) or the Company pursuant to Section 7.1(f), then the Company shall pay to Parent prior to or concurrently with such termination, in the case of a termination by the Company, or within two (2) Business Days thereafter, in the case of a termination by Parent, the Company Termination Fee.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "termination_fee_superior_proposal",
        "answer": "$132,000,000",
        "summary": "The Company must pay a termination fee of $132,000,000 to the Parent if it terminates the agreement to pursue a Superior Proposal.",
        "confidence": 1.0,
        "reason": "The document explicitly defines the 'Company Termination Fee' as $132,000,000 in the context of termination for a Superior Proposal.",
        "clause_text": "The 'Company Termination Fee' means one hundred thirty two million dollars ($132,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      }
    ],
    "termination_fee_company_shareholder_approval": [
      {
        "section": "termination",
        "field_name": "termination_fee_company_shareholder_approval_failure_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not specify a termination fee triggered by failure to obtain shareholder approval without involving a superior proposal.",
        "clause_text": "The parties hereto agree that if this Agreement is terminated by Parent pursuant to Section 7.1(e) or the Company pursuant to Section 7.1(f), then the Company shall pay to Parent prior to or concurrently with such termination, in the case of a termination by the Company, or within two (2) Business Days thereafter, in the case of a termination by Parent, the Company Termination Fee.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "termination_fee_company_shareholder_approval_failure",
        "answer": "132000000",
        "summary": "The Company Termination Fee is specified as one hundred thirty-two million dollars ($132,000,000) if the agreement is terminated due to failure to obtain shareholder approval.",
        "confidence": 0.9,
        "reason": "The document specifies the Company Termination Fee amount in the event of termination due to failure to obtain shareholder approval.",
        "clause_text": "The 'Company Termination Fee' means one hundred thirty two million dollars ($132,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee_shareholder_approval": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_shareholder_approval_failure_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no clause requiring the Parent to pay a Reverse Termination Fee upon failure to obtain its shareholder approval.",
        "clause_text": "The parties hereto agree that if this Agreement is terminated by Parent pursuant to Section 7.1(e) or the Company pursuant to Section 7.1(f), then the Company shall pay to Parent prior to or concurrently with such termination, in the case of a termination by the Company, or within two (2) Business Days thereafter, in the case of a termination by Parent, the Company Termination Fee.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      },
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_shareholder_approval_failure",
        "answer": "Not specified",
        "summary": "The document does not explicitly state the amount the Parent is obligated to pay to the Company if the agreement is terminated due to failure to obtain the Parent's shareholder approval.",
        "confidence": 0.8,
        "reason": "The document sections provided do not contain a specific clause detailing a reverse termination fee payable by the Parent for failure to obtain shareholder approval.",
        "clause_text": "The parties hereto agree that (A) if this Agreement is terminated by Parent or the Company pursuant to (x) Section 7.1(c) (but solely to the extent a court of competent jurisdiction or other Governmental Entity of competent jurisdiction shall have issued an Order pursuant to a Regulatory Law (and no other Law), adopted or caused to be effective any Law (but solely to the extent it is a Regulatory Law and no other Law) or taken any other action pursuant to a Regulatory Law (and no other Law), in each case, permanently restraining, enjoining or otherwise prohibiting, prior to the Effective Time, the consummation of the Merger, and such Order or other action shall have become final and non-appealable), or (y) Section 7.1(d), (B) at the time of such termination, all of the conditions in Article 6 other than Section 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied or are capable of being satisfied prior to Closing (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, and (C) at the time of such termination the Company is not in material breach of any representation, warranty, covenant or other agreement of the Company set forth in this Agreement where such breach by the Company is the primary cause of the failure of any condition to this Agreement being satisfied, then Parent shall pay to the Company prior to or concurrently with such termination, in the case of a termination by Parent, or within two (2) Business Days thereafter, in the case of a termination by the Company, the Parent Termination Fee. The 'Parent Termination Fee' means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "termination_rights": [
      {
        "section": "termination",
        "field_name": "mutual_termination_rights",
        "answer": [
          "By mutual written consent of Parent and the Company, by action of their respective boards of directors, at any time prior to the Effective Time",
          "By either the Company or Parent, if the Company Shareholder Approval shall not have been obtained at the Company Meeting or any adjournment thereof",
          "By either the Company or Parent, if (i) any court of competent jurisdiction or other Governmental Entity of competent jurisdiction shall have issued an Order or taken any other action, in each case, permanently restraining, enjoining or otherwise prohibiting, prior to the Effective Time, the consummation of the Merger, and such Order or other action shall have become final and non-appealable (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole), or (ii) any Governmental Entity shall have adopted or caused to be effective any Law prohibiting, prior to the Effective Time, the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole); provided that the right to terminate this Agreement pursuant to this Section 7.1(c) will not be available to any party where material failure to fulfill any obligation under this Agreement has been the principal cause of, or resulted in, such Order or other action",
          "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date'); provided, however, that the right to terminate this Agreement pursuant to this Section 7.1(d) will not be available to any party whose material breach of any representation, warranty, covenant or agreement set forth in this Agreement has principally caused, or resulted in, the Effective Time not occurring prior to the Outside Date"
        ],
        "summary": "The agreement allows mutual termination by mutual consent, failure to obtain shareholder approval, issuance of a prohibitive order or law, or failure to close by the outside date.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "This Agreement may be terminated, and the Merger and the other Transactions may be abandoned at any time prior to the Effective Time, whether before or (subject to the terms hereof) after receipt of the Company Shareholder Approval, by action taken or authorized by the board of directors of the terminating party or parties: (a) By mutual written consent of Parent and the Company, by action of their respective boards of directors, at any time prior to the Effective Time; (b) By either the Company or Parent, if the Company Shareholder Approval shall not have been obtained at the Company Meeting or any adjournment thereof; (c) By either the Company or Parent, if (i) any court of competent jurisdiction or other Governmental Entity of competent jurisdiction shall have issued an Order or taken any other action, in each case, permanently restraining, enjoining or otherwise prohibiting, prior to the Effective Time, the consummation of the Merger, and such Order or other action shall have become final and non-appealable (other than any such Order issued pursuant to or to enforce a Regulatory Law, which Order is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole), or (ii) any Governmental Entity shall have adopted or caused to be effective any Law prohibiting, prior to the Effective Time, the consummation of the Merger (other than any Regulatory Law that is not material to Parent and its Subsidiaries (assuming consummation of the Transactions), taken as a whole); provided that the right to terminate this Agreement pursuant to this Section 7.1(c) will not be available to any party where material failure to fulfill any obligation under this Agreement has been the principal cause of, or resulted in, such Order or other action; (d) By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date'); provided, however, that the right to terminate this Agreement pursuant to this Section 7.1(d) will not be available to any party whose material breach of any representation, warranty, covenant or agreement set forth in this Agreement has principally caused, or resulted in, the Effective Time not occurring prior to the Outside Date",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      },
      {
        "section": "termination",
        "field_name": "parent_termination_rights",
        "answer": [
          "By Parent if at any time (i) prior to the receipt of the Company Shareholder Approval, the Company Board shall have effected a Company Change of Recommendation or (ii) a Willful and Material Breach of Section 5.5 (No Solicitation) shall have occurred (or be deemed, pursuant to the terms thereof, to have occurred);",
          "By Parent, at any time prior to the Effective Time, if: (i) there has been a breach by the Company of its representations, warranties or covenants contained in this Agreement, in each case, such that any condition to the Merger contained in Sections 6.3(a) or 6.3(b) is not reasonably capable of being satisfied while such breach is continuing, (ii) Parent shall have delivered to the Company written notice of such breach and (iii) such breach is not capable of cure in a manner sufficient to allow satisfaction of the conditions in Sections 6.3(a) and 6.3(b) prior to the Outside Date (as the same may be extended) or at least thirty (30) days shall have elapsed since the date of delivery of such written notice to the Company and such breach shall not have been cured in all material respects; provided, however, that Parent shall not be permitted to terminate this Agreement pursuant to this Section 7.1(g) if there has been any material breach by Parent or Merger Sub of its material representations, warranties or covenants contained in this Agreement, and such breach shall not have been cured in all material respects;"
        ],
        "summary": "Parent has the unilateral right to terminate the agreement if the Company Board changes its recommendation or breaches the no-solicitation clause, or if the Company breaches its representations, warranties, or covenants, making merger conditions unsatisfiable.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "By Parent if at any time (i) prior to the receipt of the Company Shareholder Approval, the Company Board shall have effected a Company Change of Recommendation or (ii) a Willful and Material Breach of Section 5.5 (No Solicitation) shall have occurred (or be deemed, pursuant to the terms thereof, to have occurred); By Parent, at any time prior to the Effective Time, if: (i) there has been a breach by the Company of its representations, warranties or covenants contained in this Agreement, in each case, such that any condition to the Merger contained in Sections 6.3(a) or 6.3(b) is not reasonably capable of being satisfied while such breach is continuing, (ii) Parent shall have delivered to the Company written notice of such breach and (iii) such breach is not capable of cure in a manner sufficient to allow satisfaction of the conditions in Sections 6.3(a) and 6.3(b) prior to the Outside Date (as the same may be extended) or at least thirty (30) days shall have elapsed since the date of delivery of such written notice to the Company and such breach shall not have been cured in all material respects; provided, however, that Parent shall not be permitted to terminate this Agreement pursuant to this Section 7.1(g) if there has been any material breach by Parent or Merger Sub of its material representations, warranties or covenants contained in this Agreement, and such breach shall not have been cured in all material respects;",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      },
      {
        "section": "termination",
        "field_name": "company_termination_rights",
        "answer": [
          "By the Company, at any time prior to the receipt of the Company Shareholder Approval, if the Company Board determines to accept a Superior Proposal, but only if the Company shall have complied in all material respects with its obligations under Section 5.5 (No Solicitation) with respect to such Superior Proposal; provided, however, that the Company shall prior to or concurrently with such termination pay the Company Termination Fee to or for the account of Parent pursuant to Section 7.3.",
          "By the Company, at any time prior to the Effective Time, if: (i) there has been a breach by Parent or Merger Sub of any of its representations, warranties or covenants contained in this Agreement, in each case, such that any condition to the Merger contained in Sections 6.2(a) or 6.2(b) is not reasonably capable of being satisfied while such breach is continuing, (ii) the Company shall have delivered to Parent written notice of such breach and (iii) either such breach is not capable of cure prior to the Outside Date (as the same may be extended) or at least thirty (30) days shall have elapsed since the date of delivery of such written notice to Parent and such breach shall not have been cured in all material respects; provided, however, that the Company shall not be permitted to terminate this Agreement pursuant to this Section 7.1(h) if there has been any material breach by the Company of its material representations, warranties or covenants contained in this Agreement, and such or breach shall not have been cured in all material respects."
        ],
        "summary": "The Company may terminate the agreement if it accepts a Superior Proposal, provided it complies with Section 5.5 and pays the Company Termination Fee, or if there is a breach by Parent or Merger Sub of representations, warranties, or covenants that cannot be cured before the Outside Date.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "By the Company, at any time prior to the receipt of the Company Shareholder Approval, if the Company Board determines to accept a Superior Proposal, but only if the Company shall have complied in all material respects with its obligations under Section 5.5 (No Solicitation) with respect to such Superior Proposal; provided, however, that the Company shall prior to or concurrently with such termination pay the Company Termination Fee to or for the account of Parent pursuant to Section 7.3. By the Company, at any time prior to the Effective Time, if: (i) there has been a breach by Parent or Merger Sub of any of its representations, warranties or covenants contained in this Agreement, in each case, such that any condition to the Merger contained in Sections 6.2(a) or 6.2(b) is not reasonably capable of being satisfied while such breach is continuing, (ii) the Company shall have delivered to Parent written notice of such breach and (iii) either such breach is not capable of cure prior to the Outside Date (as the same may be extended) or at least thirty (30) days shall have elapsed since the date of delivery of such written notice to Parent and such breach shall not have been cured in all material respects; provided, however, that the Company shall not be permitted to terminate this Agreement pursuant to this Section 7.1(h) if there has been any material breach by the Company of its material representations, warranties or covenants contained in this Agreement, and such or breach shall not have been cured in all material respects.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      }
    ],
    "termination_fee_events": [
      {
        "section": "termination",
        "field_name": "company_termination_fee_events",
        "answer": [
          "Termination by Parent pursuant to Section 7.1(e)",
          "Termination by the Company pursuant to Section 7.1(f)",
          "Termination pursuant to Section 7.1(b), Section 7.1(d) or Section 7.1(g) with a Competing Proposal received or announced and not withdrawn, and a definitive agreement or transaction consummated within twelve months"
        ],
        "summary": "The Company is required to pay a termination fee if the agreement is terminated by Parent under Section 7.1(e), by the Company under Section 7.1(f), or if terminated under Sections 7.1(b), 7.1(d), or 7.1(g) with a Competing Proposal received or announced and not withdrawn, and a definitive agreement or transaction consummated within twelve months.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The parties hereto agree that if this Agreement is terminated by Parent pursuant to Section 7.1(e) or the Company pursuant to Section 7.1(f), then the Company shall pay to Parent prior to or concurrently with such termination... if (x) this Agreement is terminated pursuant to Section 7.1(b), Section 7.1(d) or Section 7.1(g), (y) after the date hereof and prior to the date of the Company Meeting, a bona fide Competing Proposal was received by the Company or has been publicly announced and not withdrawn before the date this Agreement is terminated and (z) the Company enters into a definitive agreement with respect to any Competing Proposal within twelve (12) months after such termination or consummates a transaction contemplated by any Competing Proposal within twelve (12) months after such termination, then the Company shall pay the Company Termination Fee to Parent...",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a), (b)"
      },
      {
        "section": "termination",
        "field_name": "parent_reverse_termination_fee_events",
        "answer": "Parent is required to pay a reverse termination fee if the Agreement is terminated by Parent or the Company pursuant to Section 7.1(c) (under specific regulatory conditions) or Section 7.1(d), provided certain conditions are met.",
        "summary": "Parent must pay the Parent Termination Fee if the Agreement is terminated under specific regulatory conditions or if the Effective Time does not occur by the specified date, given certain conditions are satisfied.",
        "confidence": 0.9,
        "reason": "The document specifies conditions under which Parent must pay the Parent Termination Fee.",
        "clause_text": "The parties hereto agree that (A) if this Agreement is terminated by Parent or the Company pursuant to (x) Section 7.1(c) (but solely to the extent a court of competent jurisdiction or other Governmental Entity of competent jurisdiction shall have issued an Order pursuant to a Regulatory Law (and no other Law), adopted or caused to be effective any Law (but solely to the extent it is a Regulatory Law and no other Law) or taken any other action pursuant to a Regulatory Law (and no other Law), in each case, permanently restraining, enjoining or otherwise prohibiting, prior to the Effective Time, the consummation of the Merger, and such Order or other action shall have become final and non-appealable), or (y) Section 7.1(d), (B) at the time of such termination, all of the conditions in Article 6 other than Section 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied or are capable of being satisfied prior to Closing (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, and (C) at the time of such termination the Company is not in material breach of any representation, warranty, covenant or other agreement of the Company set forth in this Agreement where such breach by the Company is the primary cause of the failure of any condition to this Agreement being satisfied, then Parent shall pay to the Company prior to or concurrently with such termination, in the case of a termination by Parent, or within two (2) Business Days thereafter, in the case of a termination by the Company, the Parent Termination Fee.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "reimbursement_obligations": [
      {
        "section": "termination",
        "field_name": "target_reimbursement_obligations",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "termination",
        "field_name": "parent_reimbursement_obligations",
        "answer": "Upon request by the Company, Parent shall promptly reimburse the Company for all reasonable and documented out-of-pocket costs and expenses (including reasonable and documented legal fees and expenses) incurred by the Company or any of its Subsidiaries in connection with providing the support and cooperation contemplated by Section 5.16(a)(i) or otherwise in connection with the Debt Financing.",
        "summary": "Parent is obligated to reimburse the Company for reasonable and documented out-of-pocket costs and expenses incurred in connection with providing support for the Debt Financing.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Upon request by the Company, Parent shall promptly reimburse the Company for all reasonable and documented out-of-pocket costs and expenses (including reasonable and documented legal fees and expenses) incurred by the Company or any of its Subsidiaries in connection with providing the support and cooperation contemplated by Section 5.16(a)(i) or otherwise in connection with the Debt Financing.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.16 Financing > (d) Company Reimbursement and Indemnification > (i)"
      }
    ],
    "regulatory_termination_fee": [
      {
        "section": "termination",
        "field_name": "regulatory_termination_fee",
        "answer": "$160,000,000",
        "summary": "The Parent Termination Fee of $160,000,000 is payable if the agreement is terminated due to a regulatory failure, such as a final and non-appealable order prohibiting the merger under a Regulatory Law.",
        "confidence": 0.9,
        "reason": "The clause specifies a Parent Termination Fee explicitly tied to regulatory-related termination conditions.",
        "clause_text": "The \"Parent Termination Fee\" means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "failure_to_close_fee": [
      {
        "section": "termination",
        "field_name": "failure_to_close_fee",
        "answer": "$132,000,000",
        "summary": "The Company Termination Fee of $132,000,000 is payable if the agreement is terminated by Parent pursuant to Section 7.1(e) or by the Company pursuant to Section 7.1(f).",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The 'Company Termination Fee' means one hundred thirty two million dollars ($132,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (a)"
      }
    ],
    "reverse_termination_fee_regulatory": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_regulatory",
        "answer": "$160,000,000",
        "summary": "The Parent is obligated to pay a reverse termination fee of $160,000,000 if the agreement is terminated due to failure to obtain regulatory approvals under specific conditions.",
        "confidence": 0.9,
        "reason": "The document specifies a Parent Termination Fee of $160,000,000 under conditions related to regulatory law failures.",
        "clause_text": "The 'Parent Termination Fee' means one hundred sixty million dollars ($160,000,000).",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees > (c)"
      }
    ],
    "extend_or_terminate_limitation_due_to_breach": [
      {
        "section": "termination",
        "field_name": "extend_or_terminate_limitation_due_to_breach",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "ordinary_course": {
    "company_ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "company_conduct_covenant_summary",
        "answer": "The target company is required to conduct its operations in all material respects in the ordinary course of business and use commercially reasonable efforts to maintain its current business relationships and workforce. Certain actions require prior written consent from the Parent, which should not be unreasonably withheld.",
        "summary": "The target company must operate in the ordinary course of business and use commercially reasonable efforts to maintain business relationships and workforce, with certain actions requiring Parent's consent.",
        "confidence": 0.95,
        "reason": "The clause explicitly outlines the company's obligations to operate in the ordinary course and use commercially reasonable efforts, with specific actions needing Parent's consent.",
        "clause_text": "Between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement in accordance with Article 7, except (1) for any Permitted Action, (2) as set forth in Section 5.1 of the Company Disclosure Schedule, (3) as required by Law or Order, (4) for any action taken to comply with any COVID-19 Measures, (5) as otherwise expressly contemplated by any other provision of this Agreement, or (6) with the prior written consent of Parent (other than with respect to Sections 5.1(e) and 5.1(l)(i), not to be unreasonably withheld, conditioned or delayed), the Company will, and will cause each of its Subsidiaries to, (i) conduct its operations in all material respects in the ordinary course of business, and (ii) use commercially reasonable efforts to keep available the services of the current officers, employees and consultants of the Company and each of its Subsidiaries and to preserve the goodwill and current relationships of the Company and each of its Subsidiaries with customers, suppliers and other Persons with which the Company or any of its Subsidiaries has significant business relations.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.1 Conduct of Business by the Company Pending the Closing"
      }
    ],
    "parent_ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "parent_conduct_covenant_summary",
        "answer": "commercially reasonable efforts",
        "summary": "The Parent is required to conduct its operations in all material respects in the ordinary course of business and use commercially reasonable efforts to maintain its current business relationships and personnel.",
        "confidence": 0.9,
        "reason": "The document specifies that Parent will conduct its operations in the ordinary course of business and use commercially reasonable efforts to maintain relationships and personnel.",
        "clause_text": "Parent will, and will cause each of its Subsidiaries (i) to conduct its operations in all material respects in the ordinary course of business, and (ii) to use commercially reasonable efforts to keep available the services of the current officers, employees and consultants of Parent and each of its Subsidiaries and to preserve the goodwill and current relationships of Parent and each of its Subsidiaries with customers, suppliers and other Persons with which Parent or any of its Subsidiaries has significant business relations.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.2 Conduct of Business by Parent Pending the Closing"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement explicitly states that the Company Board has unanimously approved the transaction.",
        "clause_text": "The Company Board, at a meeting duly called and held in compliance with the requirements of the memorandum and articles of association of the Company, unanimously adopted resolutions (i) determining that the Transactions, including the Merger, are advisable, fair to and in the best interests of the Company and its shareholders, (ii) approving, adopting and declaring advisable this Agreement and the Transactions, including the Merger...",
        "reference_section": "ARTICLE Article 3 Representations and Warranties of the Company > Section 3.4 Authority; Execution and Delivery; Enforceability"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that the Company Board unanimously adopted resolutions approving the merger.",
        "clause_text": "The Company Board, at a meeting duly called and held in compliance with the requirements of the memorandum and articles of association of the Company, unanimously adopted resolutions (i) determining that the Transactions, including the Merger, are advisable, fair to and in the best interests of the Company and its shareholders, (ii) approving, adopting and declaring advisable this Agreement and the Transactions, including the Merger, (iii) directing that this Agreement be submitted to the shareholders of the Company for its adoption, and (iv) recommending that the Company's shareholders adopt this Agreement.",
        "reference_section": "ARTICLE Article 3 Representations and Warranties of the Company > Section 3.4 Authority; Execution and Delivery; Enforceability"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement explicitly states that the Parent Board has approved the transaction.",
        "clause_text": "C. The Board of Directors of Parent (\"Parent Board\") has, upon the terms and subject to the conditions set forth herein, approved this Agreement and the transactions contemplated hereby, including the Merger and the issuance of shares of Parent Common Stock as consideration in the Merger (the \"Share Issuance\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of unanimous approval by the Parent Board in the provided excerpts.",
        "clause_text": "The Board of Directors of Parent (\"Parent Board\") has, upon the terms and subject to the conditions set forth herein, approved this Agreement and the transactions contemplated hereby, including the Merger and the issuance of shares of Parent Common Stock as consideration in the Merger (the \"Share Issuance\").",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "MAXLINEAR, INC.",
        "summary": "The acquiring entity in the merger agreement is MAXLINEAR, INC., a Delaware corporation.",
        "confidence": 0.95,
        "reason": "The preamble explicitly states that MAXLINEAR, INC. is the Parent and initiator of the transaction.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "MAXLINEAR, INC.",
        "summary": "MAXLINEAR, INC. is the ultimate parent company of Merger Sub, which is a wholly owned subsidiary formed solely for the purposes of the merger.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that Merger Sub is a wholly owned subsidiary of Parent, which is identified as MAXLINEAR, INC.",
        "clause_text": "All of the issued and outstanding Equity Interests of Merger Sub are, and at the Effective Time will be, owned directly or indirectly by Parent.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.16 Ownership of Merger Sub"
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "Silicon Motion Technology Corporation",
        "summary": "The target company being acquired is Silicon Motion Technology Corporation, as it is defined as 'the Company' in the agreement.",
        "confidence": 1.0,
        "reason": "The agreement explicitly defines 'the Company' as Silicon Motion Technology Corporation, which is the entity being merged into by Merger Sub.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "guarantor": [
      {
        "section": "party_details",
        "field_name": "guarantor_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly identify a separate guarantor distinct from Parent or Merger Sub that guarantees their obligations.",
        "clause_text": "Parent hereby guarantees the due, prompt and faithful payment, performance and discharge by Merger Sub of, and the compliance by Merger Sub with, all of the covenants, agreements, obligations and undertakings of Merger Sub under this Agreement in accordance with the terms of this Agreement.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.11 Parent Agreements Concerning Merger Sub"
      },
      {
        "section": "party_details",
        "field_name": "guarantor_details",
        "answer": "Not Found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit reference to any subsidiaries of the target company being directly involved in the merger structure.",
        "clause_text": "The document sections provided do not mention any subsidiaries of the target company in relation to the merger mechanics.",
        "reference_section": "Various sections reviewed, no specific reference found."
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "Merger Sub, a subsidiary of the Parent, is explicitly referenced as being directly involved in the merger structure.",
        "clause_text": "Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate existence of Merger Sub shall cease to exist and will be struck off the Register of Companies in the Cayman Islands, and the Company shall continue as the Surviving Company under the Laws of the Cayman Islands and become a wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.1 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Shark Merger Sub\", \"clause_reference\": \"Section 1.1\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "Shark Merger Sub is explicitly referenced as a wholly owned subsidiary of the Parent, formed solely for the purpose of merging with the target company.",
        "confidence": 0.95,
        "reason": "The document specifies that Merger Sub is formed solely for the purposes of the merger, indicating its direct involvement in the merger structure.",
        "clause_text": "Merger Sub was formed solely for purposes of the Merger and, except for matters incident to formation and execution and delivery of this Agreement and the performance of the Transactions, has not prior to the date hereof engaged in any business or other activities.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.16 Ownership of Merger Sub"
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction involves Merger Sub merging with and into the Company, with the Company continuing as the surviving entity and becoming a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure described matches the characteristics of a Reverse Triangular Merger, where the subsidiary merges into the target, and the target survives.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the CICA, at the Effective Time, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate existence of Merger Sub shall cease to exist and will be struck off the Register of Companies in the Cayman Islands, and the Company shall continue as the Surviving Company under the Laws of the Cayman Islands and become a wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.1 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "The transaction is structured as a merger where Merger Sub will merge with and into the Company, resulting in the Company continuing as the Surviving Company and becoming a wholly owned subsidiary of Parent.",
        "summary": "The transaction is structured as a merger where Merger Sub will merge with and into the Company, resulting in the Company continuing as the Surviving Company and becoming a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The document explicitly describes the merger structure, including the roles of Merger Sub and the Company.",
        "clause_text": "Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the CICA, at the Effective Time, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate existence of Merger Sub shall cease to exist and will be struck off the Register of Companies in the Cayman Islands, and the Company shall continue as the Surviving Company under the Laws of the Cayman Islands and become a wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.1 The Merger"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands ('Merger Sub'), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the 'Company').",
        "summary": "Merger Sub is SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands, and is a direct wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The document explicitly states the full legal name, jurisdiction of incorporation, and ownership relationship of Merger Sub.",
        "clause_text": "SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands ('Merger Sub'), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the 'Company').",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "2nd Business Day after satisfaction or waiver of all applicable conditions in Article 6, or the earlier of any Business Day before or during the Marketing Period specified by Parent with notice, or the 2nd Business Day after the final day of the Marketing Period.",
        "summary": "The closing date is set for the 2nd Business Day after all conditions in Article 6 are satisfied or waived, or earlier if specified by Parent during the Marketing Period.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date based on the satisfaction of conditions and the Marketing Period.",
        "clause_text": "The closing of the Merger (the 'Closing') will take place at 8:30 p.m. (Taiwan time) as soon as practicable, but in any event no later than the second (2nd) Business Day after satisfaction or waiver of all of the applicable conditions set forth in Article 6... if the Marketing Period has not ended... the Closing shall not occur until the date that is the earlier of (a) any Business Day before or during the Marketing Period specified by Parent... and (b) the second (2nd) Business Day after the final day of the Marketing Period.",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.2 Closing and Effective Time of the Merger"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The term 'Marketing Period' is explicitly defined and referenced in connection with closing timing.",
        "clause_text": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Marketing Period"
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained; provided that (x) (1) none of July 5, 2022, July 3, 2023 or July 5, 2023 shall be considered a calendar day for the purposes of this definition (provided, however, that such exclusion shall not restart such period) and (2) if such fifteen (15) consecutive calendar day period has not ended on or prior to (A) August 22, 2022, then it will be deemed to not commence earlier than September 6, 2022, or (B) December 16, 2022, then it will be deemed to not commence earlier than January 2, 2023, (y) in no event shall the Marketing Period be restarted or cease to continue if additional financial statements are required to be delivered pursuant to the definition of \"Required Financial Information\" or have otherwise been provided after the Marketing Period has commenced, and (z) the Marketing Period in any event shall end on any earlier date prior to the expiration of such fifteen (15) consecutive calendar day period if the Debt Financing is consummated on such earlier date (including closing into escrow); provided, further, that if the Company shall in good faith reasonably believe that it has provided the Required Financial Information, the Company may deliver to Parent a written notice to that effect (stating in good faith when it believes it completed such delivery), in which case the Company shall be deemed to have delivered the Required Financial Information on the date specified in such notice, unless Parent in good faith reasonably believes that the Company has not completed the delivery of the Required Financial Information at the time such notice is given and, within three (3) Business Days after the date of the delivery of such notice by the Company, Parent gives written notice to the Company to that effect (stating with reasonable specificity which such Required Financial Information has not been delivered), in which case such Required Financial Information shall be deemed to have been delivered when such specific items have been delivered by the Company; provided, that such written notice from Parent to the Company will not prejudice the Company's right to assert that the Required Financial Information was, in fact, delivered; provided, further, that, notwithstanding the foregoing, the delivery of the Required Financial Information shall be satisfied at any time at which (and so long as) Parent shall have actually received the Required Financial Information, regardless of whether any such notice is delivered to the Company.",
        "summary": "The Marketing Period is a 15-day period starting after the Parent has access to Required Financial Information and Company Shareholder Approval is obtained. Specific dates are excluded, and the period may be adjusted based on certain conditions.",
        "confidence": 1.0,
        "reason": "The definition is explicitly provided in the document, detailing conditions, exclusions, and adjustments.",
        "clause_text": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained; provided that (x) (1) none of July 5, 2022, July 3, 2023 or July 5, 2023 shall be considered a calendar day for the purposes of this definition...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Marketing Period"
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document does not explicitly define or reference an 'Inside Date' as a deadline or milestone prior to the Outside Date.",
        "clause_text": "The document references the 'Outside Date' but does not mention an 'Inside Date'.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement expressly states that the parties are entitled to specific performance as a remedy.",
        "clause_text": "The parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "Company, Parent",
        "summary": "Both the Company and Parent are entitled to seek specific performance as per the agreement terms.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Company's or Parent's pursuit of specific performance at any time will not be deemed an election of remedies or waiver of the right to pursue any other right or remedy to which such party may be entitled, including the right to pursue remedies for liabilities or damages incurred or suffered by the other party in the case of a breach of this Agreement involving fraud or a Willful and Material Breach.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "There are no specific limitations or conditions imposed on the right to seek specific performance.",
        "summary": "The agreement allows parties to seek specific performance without requiring the securing or posting of any bond and waives the defense of adequacy of a remedy at Law.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the entitlement to specific performance and waives certain defenses, implying no additional limitations.",
        "clause_text": "The parties hereto agree that if any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, irreparable damage would occur, no adequate remedy at Law would exist and damages would be difficult to determine, and accordingly, (i) the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to specific performance of the terms hereof, this being in addition to any other remedy to which they are entitled at Law or in equity, (ii) the parties waive any requirement for the securing or posting of any bond in connection with the obtaining of any specific performance or injunctive relief and (iii) the parties will waive, in any action for specific performance, the defense of adequacy of a remedy at Law.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.13 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document explicitly states that the obligation to consummate the transactions is not contingent upon the availability of financing.",
        "clause_text": "Parent understands and acknowledges that under the terms of this Agreement, Parent's obligation to consummate the transactions contemplated by this Agreement is not in any way contingent upon or otherwise subject to Parent's consummation of any financing arrangements, Parent's obtaining of any financing or the availability, grant, provision or extension of any financing to Parent.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "Parent's obligation to consummate the transactions is not contingent upon obtaining financing.",
        "summary": "The agreement specifies that Parent's obligation to consummate the transactions is not contingent upon obtaining financing, as stated in the clause that Parent acknowledges this obligation is not subject to financing arrangements.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the obligation to consummate the transactions is not contingent upon financing.",
        "clause_text": "Parent understands and acknowledges that under the terms of this Agreement, Parent's obligation to consummate the transactions contemplated by this Agreement is not in any way contingent upon or otherwise subject to Parent's consummation of any financing arrangements, Parent's obtaining of any financing or the availability, grant, provision or extension of any financing to Parent.",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing"
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly references a confidentiality agreement between the parties.",
        "clause_text": "The Confidentiality Agreement, dated March 17, 2022, by and between the Company and Parent (the 'Confidentiality Agreement'), shall apply with respect to information furnished under this Section 5.4(a) by the Company, its Subsidiaries and their Representatives.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.4 Access to Information; Confidentiality"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "March 17, 2022",
        "summary": "The confidentiality agreement was signed on March 17, 2022, as indicated in the document.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "The Confidentiality Agreement, dated March 17, 2022, by and between the Company and Parent (the \"Confidentiality Agreement\"), shall apply with respect to information furnished under this Section 5.4(a) by the Company, its Subsidiaries and their Representatives.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.4 Access to Information; Confidentiality"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_amendment_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no explicit mention of any amendment or modification to the confidentiality agreement.",
        "clause_text": "This Agreement (together with the Exhibits and Company Disclosure Schedule and the other documents delivered pursuant hereto) and the Confidentiality Agreement constitute the entire agreement of the parties and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.7 Entire Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_amendment_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no reference to a Clean Room or Clean Team arrangement in the provided excerpts.",
        "clause_text": "No relevant text found referencing a Clean Room or Clean Team arrangement.",
        "reference_section": "NA"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "the earlier of the Effective Time or the termination of this Agreement",
        "summary": "Clean Room access terminates at the earlier of the Effective Time or the termination of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies that certain obligations, including Clean Room access, continue until the earlier of the Effective Time or termination.",
        "clause_text": "From and after the date of this Agreement until the earlier of the Effective Time or the termination of this Agreement in accordance with Article 7...",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.7 Certain Notices"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "The Clean Room use is restricted by access limitations, team structure, data scope, and functional boundaries.",
        "summary": "The Clean Room use is restricted by access limitations, team structure, data scope, and functional boundaries.",
        "confidence": 0.9,
        "reason": "The clause specifies access limitations, team structure, data scope, and functional boundaries for Clean Room use.",
        "clause_text": "The Company may, as it deems advisable and necessary, reasonably designate any competitively sensitive material to be provided to the other under this Section 5.4(a) as 'Outside Counsel Only Material.' Such materials and information contained therein shall be given only to the outside legal counsel of the recipient and will not be disclosed by such outside legal counsel to employees (including in-house legal counsel), officers, directors or other independent contractors (including accountants and expert witnesses) of the recipient unless express permission is obtained in advance from the source of the materials or its legal counsel.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.4 Access to Information; Confidentiality > (a)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement includes a clause that requires the Company to revoke or withdraw access to any data room or non-public information in connection with a Competing Proposal.",
        "clause_text": "The Company shall immediately cease... and to revoke or withdraw access of any Person (other than Parent, Merger Sub and their Representatives) to any data room (virtual or actual) hosted by the Company or any of its Subsidiaries or Representatives containing, or any other access to, any non-public information with respect to the Company or its Subsidiaries in connection with a Competing Proposal.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.5 No Solicitation > (b)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "The agreement contains provisions that result in the revocation of the Company's access to clean room or confidential information in connection with a Superior Proposal.",
        "summary": "The Company must revoke or withdraw access to any data room or non-public information for any person other than Parent, Merger Sub, and their representatives in connection with a Competing Proposal.",
        "confidence": 0.9,
        "reason": "The clause explicitly requires the Company to revoke access to non-public information for third parties in connection with a Competing Proposal.",
        "clause_text": "The Company shall immediately cease, any and all existing discussion, activities or negotiations with any Person (other than Parent, Merger Sub or any of their respective designees or Representatives) conducted heretofore with respect to any Competing Proposal and to revoke or withdraw access of any Person (other than Parent, Merger Sub and their Representatives) to any data room (virtual or actual) hosted by the Company or any of its Subsidiaries or Representatives containing, or any other access to, any non-public information with respect to the Company or its Subsidiaries in connection with a Competing Proposal.",
        "reference_section": "ARTICLE V – Covenants > Section 5.5 – No Solicitation > (b)"
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "$23.385 per Share and 0.097 shares of Parent Common Stock per Share",
        "summary": "The total consideration offered to target shareholders includes $23.385 in cash per Share and 0.097 shares of Parent Common Stock per Share.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "$23.385 per Share and 0.097 shares of Parent Common Stock per Share; $93.54 per ADS and 0.388 shares of Parent Common Stock per ADS",
        "summary": "The merger consideration includes $23.385 in cash and 0.097 shares of Parent Common Stock per ordinary share, and $93.54 in cash and 0.388 shares of Parent Common Stock per ADS.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Each ordinary share... shall be cancelled in exchange for the right to receive (i) $23.385 per Share... and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock... Each ADS... shall be cancelled in exchange for the right to receive (i) $93.54 per ADS... and (ii) 0.388 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "is_all_cash_deal",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that each share is converted into both cash and shares of Parent Common Stock, indicating a non-cash component.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time... shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement provides for proration between different types of consideration, specifically cash and stock.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company... shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the 'Per Share Cash Merger Consideration'), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "Shareholders are allowed to elect among different types of consideration, as they can receive both cash and shares of Parent Common Stock.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company... shall be cancelled in exchange for the right to receive (i) $23.385 per Share... and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share is automatically converted into a fixed combination of cash and stock.",
        "confidence": 0.95,
        "reason": "The language specifies that shares are automatically cancelled and converted into a fixed cash and stock consideration without any action by the shareholders.",
        "clause_text": "At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub, the Company or the holders of any of the following securities: (a) Cancellation of Shares. Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of a Contingent Value Right (CVR) in the provided document excerpts.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of any ticking fee, time-based fee, or incremental increase in consideration payable over time due to delay in the provided excerpts.",
        "clause_text": "The provided excerpts do not contain any reference to ticking fees or similar provisions.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.3 Termination Fees"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "There is no mention of contingent payments beyond CVRs in the provided document excerpts.",
        "clause_text": "The provided document excerpts do not mention any contingent payments beyond CVRs.",
        "reference_section": "complex_consideration_and_dividends > contingent_payments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger agreement prohibits the target company from declaring or paying dividends without prior written consent from the Parent.",
        "clause_text": "the Company shall not, and shall not permit any of its Subsidiaries to, ... (e) declare, set aside, make or pay any dividend or other distribution ... without the prior written consent of Parent",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.1 Conduct of Business by the Company Pending the Closing"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement prohibits the parent company from declaring or paying dividends without the prior written consent of the Company.",
        "clause_text": "Parent shall not, and shall not permit any of its Subsidiaries to, ... declare, set aside, make or pay any dividend or other distribution ... with respect to any of its capital stock or other Equity Interests; or ... without the prior written consent of the Company.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.2 Conduct of Business by Parent Pending the Closing"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "No Dividends Allowed",
        "summary": "The merger agreement explicitly prohibits the Parent from declaring or paying any dividends or other distributions with respect to its capital stock or other Equity Interests, except for dividends or distributions paid by a wholly owned Subsidiary of Parent to Parent or another wholly owned Subsidiary of Parent.",
        "confidence": 1,
        "reason": "The agreement explicitly restricts the Parent from declaring or paying dividends without prior written consent.",
        "clause_text": "Without limiting the foregoing, except (w) for any Permitted Action, (x) as required by Law or Order, (y) for any action taken to comply with any COVID-19 Measures or (z) as otherwise expressly contemplated by any other provision of this Agreement, Parent shall not, and shall not permit any of its Subsidiaries to, between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement in accordance with Article 7, directly or indirectly, take any of the following actions without the prior written consent of the Company (not to be unreasonably withheld, conditioned or delayed): (a) amend or otherwise change the certificate of incorporation and bylaws or any other organizational documents of Parent or any of its Subsidiaries; (b) except for dividends or other distributions paid by a wholly owned Subsidiary of Parent to Parent or another wholly owned Subsidiary of Parent, declare, set aside, make or pay any dividend or other distribution (whether payable in cash, stock, property or a combination thereof) with respect to any of its capital stock or other Equity Interests; or (c) authorize or enter into any Contract or otherwise make any commitment to do any of the foregoing.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.2 Conduct of Business by Parent Pending the Closing"
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "The document describes a fixed exchange ratio and cash consideration without mentioning any collar provision that adjusts consideration based on stock price movement.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock...",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement defines a specific exchange ratio for the merger consideration.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company... shall be cancelled in exchange for the right to receive... 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_summary",
        "answer": "0.097",
        "summary": "Each ordinary share of the Company will be exchanged for 0.097 shares of Parent Common Stock.",
        "confidence": 0.95,
        "reason": "The document explicitly states the exchange ratio for each ordinary share of the Company.",
        "clause_text": "Each ordinary share, par value $0.01 per share, of the Company (each, a \"Share\" and collectively, the \"Shares\") issued and outstanding immediately prior to the Effective Time, other than the Excluded Shares, Dissenting Shares and Shares represented by each American Depositary Share, representing four (4) Shares (each, an \"ADS\" or, collectively, the \"ADSs\"), shall be cancelled in exchange for the right to receive (i) $23.385 per Share (the \"Per Share Cash Merger Consideration\"), and (ii) 0.097 validly issued, fully paid and nonassessable shares of Parent Common Stock.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.1 Conversion of Securities > (a)"
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly provides for an equitable adjustment to the Merger Consideration in the event of changes such as stock splits, stock dividends, or recapitalizations.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism is designed to equitably adjust the Merger Consideration in the event of changes in the outstanding Shares due to stock splits, dividends, recapitalizations, or similar events.",
        "summary": "The exchange ratio adjustment mechanism is designed to equitably adjust the Merger Consideration in the event of changes in the outstanding Shares due to stock splits, dividends, recapitalizations, or similar events.",
        "confidence": 0.9,
        "reason": "The clause specifies that the Merger Consideration will be equitably adjusted to reflect changes in outstanding Shares.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The merger consideration is adjusted to reflect stock dividends or similar events prior to closing.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event.",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "The merger consideration will be equitably adjusted if any stock dividend is paid before closing.",
        "summary": "The merger consideration will be equitably adjusted to reflect any stock dividend paid before closing to maintain the same economic effect as originally contemplated.",
        "confidence": 0.9,
        "reason": "The clause specifies that the merger consideration shall be equitably adjusted to reflect any stock dividend.",
        "clause_text": "In the event that, between the date of this Agreement and the Effective Time, any change in the outstanding Shares shall occur as a result of any stock split, reverse stock split, stock dividend (including any dividend or distribution of Equity Interests convertible into or exchangeable for Shares), recapitalization, reclassification, reorganization, subdivision, combination, exchange of shares, or other similar event, the Merger Consideration shall be equitably adjusted to reflect such event and to provide to holders of Shares and ADS the same economic effect as contemplated by this Agreement prior to such event;",
        "reference_section": "ARTICLE Article 2 Conversion of Securities IN THE MERGER > Section 2.6 Adjustments"
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that it is governed by the laws of the Cayman Islands and Delaware for specific provisions.",
        "clause_text": "This Agreement and all claims, disputes, controversies and causes of action (whether at Law, in contract, in tort or otherwise) arising in connection with, out of or in any way relating to this Agreement (\"Relevant Matters\") shall be governed by, and construed in accordance with, the Laws of the Cayman Islands, without regard to Laws that may be applicable under conflicts of laws principles that would cause the application of the Laws of any jurisdiction other than the Cayman Islands; provided, however, that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Cayman Islands",
        "summary": "The governing law jurisdiction for the agreement is the Cayman Islands, as specified for all claims, disputes, controversies, and causes of action arising in connection with the agreement.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "This Agreement and all claims, disputes, controversies and causes of action (whether at Law, in contract, in tort or otherwise) arising in connection with, out of or in any way relating to this Agreement (\"Relevant Matters\") shall be governed by, and construed in accordance with, the Laws of the Cayman Islands, without regard to Laws that may be applicable under conflicts of laws principles that would cause the application of the Laws of any jurisdiction other than the Cayman Islands;",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      }
    ],
    "incorporation_details": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "parent_incorporation_details",
        "answer": "a Delaware corporation",
        "summary": "The Parent entity, MaxLinear, Inc., is incorporated as a Delaware corporation.",
        "confidence": 1.0,
        "reason": "The document explicitly states the incorporation details of the Parent entity.",
        "clause_text": "AGREEMENT AND PLAN OF MERGER This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "company_incorporation_details",
        "answer": "an exempted company incorporated with limited liability, validly existing and in good standing under the Laws of the Cayman Islands",
        "summary": "The Company is described as an exempted company incorporated with limited liability under the Laws of the Cayman Islands.",
        "confidence": 1.0,
        "reason": "The document explicitly states the incorporation details of the Company.",
        "clause_text": "The Company is an exempted company incorporated with limited liability, validly existing and in good standing under the Laws of the Cayman Islands and has the requisite corporate power and authority to own, lease and operate all of its properties and assets and to carry on its business as it is now being conducted.",
        "reference_section": "ARTICLE Article 3 Representations and Warranties of the Company > Section 3.1 Corporate Organization"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by the law of the state of Delaware.",
        "clause_text": "provided, however, that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "Delaware",
        "summary": "The provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the law of the state of Delaware governs the definition or occurrence of a Material Adverse Effect.",
        "clause_text": "provided, however, that provisions related to the definition or occurrence of a Company Material Adverse Effect or a Parent Material Adverse Effect will be governed by, and construed in accordance with, the law of the state of Delaware.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (a)"
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement specifies that disputes related to the Debt Financing will be governed by the laws of the State of New York and resolved in specific courts in New York.",
        "clause_text": "any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "State of New York",
        "summary": "The jurisdiction for financing-related matters is governed by the laws of the State of New York, as specified for actions against the Financing Sources.",
        "confidence": 0.9,
        "reason": "The document explicitly states that any action against the Financing Sources related to the Agreement or Debt Financing shall be governed by the laws of the State of New York.",
        "clause_text": "any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Sources relating to this Agreement or the Debt Financing or any of the transactions contemplated hereby or thereby, including but not limited to any dispute arising out of or relating in any way to the Debt Commitment Letter or the performance thereof, shall be governed by, and construed in accordance with, the laws of the State of New York",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (c)"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement mandates binding arbitration for dispute resolution as specified in Section 8.11.",
        "clause_text": "Subject to paragraph (a) above, any Relevant Matters... shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (the 'SIAC') and resolved in accordance with the SIAC's Arbitration Rules...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (b)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Singapore International Arbitration Centre (SIAC)",
        "summary": "The arbitration clause specifies that any Relevant Matters shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (SIAC) and resolved in accordance with the SIAC's Arbitration Rules.",
        "confidence": 1.0,
        "reason": "The document explicitly states that arbitration will be administered by the Singapore International Arbitration Centre (SIAC).",
        "clause_text": "Subject to paragraph (a) above, any Relevant Matters...shall be submitted to binding arbitration administered by the Singapore International Arbitration Centre (the \"SIAC\") and resolved in accordance with the SIAC's Arbitration Rules in force at the time of the arbitration...",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.11 Governing Law; Consent to Jurisdiction; Waiver of Trial by Jury > (b)"
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "The agreement explicitly mentions a fully executed debt commitment letter, indicating committed financing.",
        "clause_text": "As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a fully executed debt commitment letter, dated as of the date of this Agreement...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing > (a)"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "The committed financing arrangements involve a Debt Financing Commitment, which includes a fully executed debt commitment letter and fee letters. The Commitment Parties have agreed to provide the financing on a several and not joint basis, subject to the terms and conditions of the Debt Financing Commitment.",
        "summary": "The committed financing arrangements involve a Debt Financing Commitment, which includes a fully executed debt commitment letter and fee letters. The Commitment Parties have agreed to provide the financing on a several and not joint basis, subject to the terms and conditions of the Debt Financing Commitment.",
        "confidence": 0.9,
        "reason": "The document provides detailed information about the Debt Financing Commitment and the involvement of Commitment Parties.",
        "clause_text": "As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a fully executed debt commitment letter, dated as of the date of this Agreement (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time to time in compliance with the terms of this Agreement, the 'Debt Commitment Letter') and fully executed fee letters (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time to time in compliance with the terms of this Agreement, the 'Fee Letters') relating thereto...",
        "reference_section": "ARTICLE Article 4 Representations and Warranties of Parent and Merger Sub > Section 4.11 Financing > (a)"
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent is obligated to use its reasonable best efforts to arrange, obtain, and complete the Debt Financing on or before the Closing Date, complying with the terms and conditions of the Debt Financing Commitment.",
        "summary": "Parent is obligated to use its reasonable best efforts to arrange, obtain, and complete the Debt Financing on or before the Closing Date, complying with the terms and conditions of the Debt Financing Commitment.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the obligation of Parent to use reasonable best efforts to secure the Debt Financing.",
        "clause_text": "Parent shall use its reasonable best efforts to arrange, obtain and complete the Debt Financing on or before the Closing Date on the terms and conditions described in the Debt Financing Commitment.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.16 Financing > (e)"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable and must use reasonable best efforts to seek substitute financing.",
        "summary": "The acquirer must promptly notify the company in writing if any portion of the Debt Financing becomes unavailable and use reasonable best efforts to arrange alternative debt financing.",
        "confidence": 0.9,
        "reason": "The agreement explicitly requires notification and efforts to obtain alternative financing if the original financing becomes unavailable.",
        "clause_text": "Parent shall promptly notify the Company in writing and Parent and Merger Sub shall use their reasonable best efforts to arrange and obtain, as promptly as practicable prior to the termination date, alternative debt financing from the same or alternative sources in an amount sufficient, together with the remaining available Financing, to consummate the Transactions.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.16 Financing > (h)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement",
        "summary": "The proxy statement or Form S-4 must be filed as promptly as reasonably practicable following the date of the Agreement and in any event within forty-five (45) days after the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the timing for filing the Form S-4 and Proxy Statement.",
        "clause_text": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a)"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "reasonable best efforts",
        "summary": "The parties must use their reasonable best efforts to have the Form S-4 declared effective under the Securities Act as promptly as reasonably practicable after filing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for 'reasonable best efforts' to make the Form S-4 effective.",
        "clause_text": "Parent shall use its reasonable best efforts, and the Company shall reasonably cooperate with Parent, to have the Form S-4 declared effective under the Securities Act as promptly as reasonably practicable after such filing.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a) > (i)"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "As promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4",
        "summary": "The shareholder meeting is expected to be held as promptly as practicable following the clearance of the Form S-4 by the SEC and within forty-five days after the mailing of the Proxy Statement and the Form S-4.",
        "confidence": 0.9,
        "reason": "The document specifies the timing for the shareholder meeting in relation to the clearance of the Form S-4 by the SEC and the mailing of the Proxy Statement.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the \"Company Meeting\") for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "45 days",
        "summary": "The shareholder meeting must be held within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline of forty-five (45) days after the mailing of the Proxy Statement and Form S-4 for holding the shareholder meeting.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the \"Company Meeting\") for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "The company is required to use its reasonable best efforts to obtain shareholder approval.",
        "summary": "The company shall solicit proxies in favor of the approval and adoption of this Agreement and use its reasonable best efforts to obtain the Company Shareholder Approval at the Company Meeting.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the company's obligation to use reasonable best efforts to obtain shareholder approval.",
        "clause_text": "Subject to the right of the Company Board to make a Company Change of Recommendation pursuant to Section 5.5, the Company shall solicit from shareholders of the Company proxies in favor of the approval and adoption of this Agreement in accordance with all applicable Laws, and shall use its reasonable best efforts to obtain the Company Shareholder Approval at the Company Meeting.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (f)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_postponment",
        "answer": "The Company may adjourn the Company Meeting for specific reasons, such as insufficient shares for a quorum or if shareholder approval is unlikely, with a limit of ten business days in aggregate and no single adjournment exceeding five business days.",
        "summary": "The Company may adjourn the Company Meeting for specific reasons, such as insufficient shares for a quorum or if shareholder approval is unlikely, with a limit of ten business days in aggregate and no single adjournment exceeding five business days.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days, and (ii) the Company shall, subject to compliance with the articles of association of the Company, adjourn the Company Meeting upon the written request of Parent (A) if as of the time that the Company Meeting is originally scheduled (as set forth in the Proxy Statement) or any adjournment thereof there are insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Meeting, or (B) if Parent reasonably determines in good faith that the Company Shareholder Approval is unlikely to be obtained, provided, further that with respect to clauses (A) and (B) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "parent_shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_timing",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_vote_efforts",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "proxy_statement",
        "field_name": "parent_shareholder_meeting_postponment",
        "answer": "The Company may adjourn the Company Meeting for up to ten (10) Business Days in the aggregate, with no single adjournment exceeding five (5) Business Days.",
        "summary": "The Company can adjourn the Company Meeting for up to ten Business Days in total, with each adjournment not exceeding five Business Days.",
        "confidence": 0.9,
        "reason": "The document specifies the conditions and limits for adjournments of the Company Meeting.",
        "clause_text": "provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The Company may adjourn the Company Meeting for specific reasons, such as insufficient shares for a quorum or if shareholder approval is unlikely, but no adjournment can exceed ten business days in total.",
        "summary": "The Company can adjourn the shareholder meeting for reasons like insufficient quorum or unlikely approval, with a maximum adjournment period of ten business days.",
        "confidence": 0.9,
        "reason": "The agreement specifies conditions under which the Company Meeting can be adjourned, with clear limits on the duration of adjournments.",
        "clause_text": "provided, further that with respect to clauses (ii) and (iii) no such adjournments shall exceed ten (10) Business Days in the aggregate and no single adjournment shall exceed five (5) Business Days",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "dissenting_shares_cap": [
      {
        "section": "proxy_statement",
        "field_name": "dissenting_shares_cap",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "May 5, 2022",
        "summary": "The merger agreement was officially signed by the parties on May 5, 2022, as indicated in the preamble of the document.",
        "confidence": 0.95,
        "reason": "The date is explicitly stated in the preamble of the agreement.",
        "clause_text": "This AGREEMENT AND PLAN OF MERGER, dated as of May 5, 2022 (this \"Agreement\"), is made by and among MAXLINEAR, INC., a Delaware corporation (\"Parent\"), SHARK MERGER SUB, an exempted company with limited liability incorporated under the Law of the Cayman Islands having a registered office at Appleby Global Services (Cayman) Limited, 71 Fort Street, George Town, Grand Cayman KY1-1106, Cayman Islands (\"Merger Sub\"), and SILICON MOTION TECHNOLOGY CORPORATION, an exempted company with limited liability incorporated under the Law of the Cayman Islands and having its registered office at Codan Trust Company (Cayman) Limited, Century Yard, Cricket Square, Hutchins Drive, P. O. Box 2681 GT, George Town, Grand Cayman, British West Indies (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "within forty-five (45) days after the date of this Agreement",
        "summary": "The preliminary Form S-4 must be prepared and filed with the SEC as promptly as reasonably practicable following the date of the Agreement and in any event within forty-five (45) days after the date of the Agreement.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the timeline for filing the preliminary Form S-4.",
        "clause_text": "As promptly as reasonably practicable following the date of this Agreement and in any event within forty-five (45) days after the date of this Agreement: (i) Parent shall prepare and file with the SEC a preliminary Form S-4.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (a)"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4",
        "summary": "The shareholder vote or consent must occur within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4.",
        "confidence": 0.9,
        "reason": "The document specifies a timeline for holding the shareholder meeting relative to the mailing of the Proxy Statement and Form S-4.",
        "clause_text": "The Company will, in accordance with the memorandum and articles of association of the Company, the Deposit Agreement, the CICA and all other applicable Laws, as promptly as practicable following the clearance of the Form S-4 by the SEC and in any event within forty-five (45) days following the mailing of the Proxy Statement and the Form S-4 (or such later date that Parent provides its prior written consent), hold a meeting of the Company shareholders (the 'Company Meeting') for the purpose of seeking the Company Shareholder Approval;",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.3 Preparation of the Form S-4; Preparation of Proxy Statement; Company Meeting > (e)"
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "February 6, 2023",
        "summary": "The initial 'Outside Date' specified in the agreement is February 6, 2023, which is the earliest date on which either party may terminate the agreement if the merger has not yet closed.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states that the Effective Time shall not have occurred on or before February 6, 2023, which is defined as the 'Original Outside Date'.",
        "clause_text": "By either the Company or Parent if the Effective Time shall not have occurred on or before February 6, 2023 (as it may be extended pursuant to this Section 7.1(d) the 'Original Outside Date');",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": [
          {
            "Extension Length": "Automatically to May 5, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "Automatically to August 7, 2023",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "All conditions in Article 6 other than Sections 6.1(c) or 6.1(d) have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "10 Business Days after the Outside Date",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Conditions to Closing in Article 6 are satisfied prior to the Outside Date",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          },
          {
            "Extension Length": "2 Business Days after the last day of any pending Matching or Marketing Period",
            "Who Grants the Extension": "Automatic",
            "Conditions to Extend": "Any pending Matching or Marketing Period",
            "Termination Restrictions Due to Breach": "Yes, the agreement restricts termination if a party's material breach caused the failure to close by the outside date."
          }
        ],
        "summary": "The Outside Date may be automatically extended under specific conditions, including satisfaction of certain conditions in Article 6 or pending periods like the Matching or Marketing Period.",
        "confidence": 0.95,
        "reason": "The agreement specifies automatic extensions based on satisfaction of conditions and pending periods.",
        "clause_text": "provided, further, that if on the Original Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to May 5, 2023 (the 'First Extended Outside Date'); provided, further, that if on the First Extended Outside Date, all of the conditions in Article 6 other than Sections 6.1(c) (solely with respect to any Regulatory Law or any Order issued pursuant to or in respect of any Regulatory Law) or 6.1(d) have been satisfied (other than conditions that by their nature can only be satisfied on the Closing Date), or have been waived by Parent and Merger Sub and the Company, as applicable, then the Outside Date shall automatically be extended to August 7, 2023 (the 'Second Extended Outside Date') (the Original Outside Date as such date may be extended by the First Extended Outside Date and the Second Extended Outside Date, as applicable, the 'Outside Date'); provided, further, that if the conditions to Closing set forth in Article 6 are satisfied prior to the Outside Date (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on Closing Date), then the definition of the applicable Outside Date shall be deemed to be extended, and shall mean, the date that is ten (10) Business Days after the Outside Date prior to giving effect to this proviso (it being understood that this proviso shall only extend the Outside Date once); provided, further, that the definition of the applicable Outside Date shall be deemed to be extended until the date that is two (2) Business Days after the last day of any then-pending (i) Matching Period or (ii) Marketing Period.",
        "reference_section": "ARTICLE Article 7 Termination, Amendment and Waiver > Section 7.1 Termination > (d)"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "15 Business Days after execution of this Agreement",
        "summary": "The pre-merger notification under the HSR Act must be prepared and filed as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline for filing the pre-merger notification under the HSR Act.",
        "clause_text": "In furtherance and not in limitation of the foregoing, each party hereto shall, in consultation and cooperation with the other: (i) prepare and file the pre-merger notification under the HSR Act as promptly as practicable but in no case later than fifteen (15) Business Days after execution of this Agreement unless otherwise agreed by the parties.",
        "reference_section": "ARTICLE Article 5 Covenants > Section 5.6 Appropriate Action; Consents; Filings > (b)"
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "The document does not provide a specific Inside Date for establishing deadlines for financing or marketing activities.",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "Marketing Period means the first period of fifteen (15) consecutive calendar days commencing on the later of (i) the date Parent shall have access to the Required Financial Information and (ii) the date the Company Shareholder Approval has been obtained; provided that (x) (1) none of July 5, 2022, July 3, 2023 or July 5, 2023 shall be considered a calendar day for the purposes of this definition (provided, however, that such exclusion shall not restart such period) and (2) if such fifteen (15) consecutive calendar day period has not ended on or prior to (A) August 22, 2022, then it will be deemed to not commence earlier than September 6, 2022, or (B) December 16, 2022, then it will be deemed to not commence earlier than January 2, 2023, (y) in no event shall the Marketing Period be restarted or cease to continue if additional financial statements are required to be delivered pursuant to the definition of \"Required Financial Information\" or have otherwise been provided after the Marketing Period has commenced, and (z) the Marketing Period in any event shall end on any earlier date prior to the expiration of such fifteen (15) consecutive calendar day period if the Debt Financing is consummated on such earlier date (including closing into escrow); provided, further, that if the Company shall in good faith reasonably believe that it has provided the Required Financial Information, the Company may deliver to Parent a written notice to that effect (stating in good faith when it believes it completed such delivery), in which case the Company shall be deemed to have delivered the Required Financial Information on the date specified in such notice, unless Parent in good faith reasonably believes that the Company has not completed the delivery of the Required Financial Information at the time such notice is given and, within three (3) Business Days after the date of the delivery of such notice by the Company, Parent gives written notice to the Company to that effect (stating with reasonable specificity which such Required Financial Information has not been delivered), in which case such Required Financial Information shall be deemed to have been delivered when such specific items have been delivered by the Company; provided, that such written notice from Parent to the Company will not prejudice the Company's right to assert that the Required Financial Information was, in fact, delivered; provided, further, that, notwithstanding the foregoing, the delivery of the Required Financial Information shall be satisfied at any time at which (and so long as) Parent shall have actually received the Required Financial Information, regardless of whether any such notice is delivered to the Company.",
        "reference_section": "ARTICLE Article 8 General Provisions > Section 8.4 Certain Definitions > Marketing Period"
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "second Business Day after satisfaction or waiver of all applicable conditions set forth in Article 6",
        "summary": "The closing of the Merger will occur no later than the second Business Day after the satisfaction or waiver of all applicable conditions set forth in Article 6.",
        "confidence": 0.9,
        "reason": "The document specifies that the closing will occur no later than the second Business Day after the satisfaction or waiver of all applicable conditions.",
        "clause_text": "The closing of the Merger (the \"Closing\") will take place at 8:30 p.m. (Taiwan time) as soon as practicable, but in any event no later than the second (2nd) Business Day after satisfaction or waiver of all of the applicable conditions set forth in Article 6...",
        "reference_section": "ARTICLE Article 1 The Merger > Section 1.2 Closing and Effective Time of the Merger"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  }
}